rfhg_22948.1

Basic information about the TSS

---

TSS ID: rfhg_22948.1 Species: human Chr: chr2		Start: 9630263 End: 9630278 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D3086081,EH38E1971923)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000460093.1:0 GeneID: 10971 HGNC/MGI_ID: HGNC:12854 UniProt_ID: Nearer transcript ids and distances:

Gene_name: YWHAQ Gene_symbol: YWHAQ Gene_synonyms: 14-3-3 HS1 Gene_source: HGNC:12854

TATA-Box annotation

---

Distance to TSS:	727
Nearest PromoterID:	NM_006826
Entrez ID:	10971
Nearest Unigene:	Hs.74405
Nearest Refseq:	NM_006826
Nearest Ensembl:	ENSG00000134308
Gene Name:	YWHAQ
Gene Alias:	14-3-3|1C5|HS1
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.500000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@YWHAQ p2@YWHAQ p3@YWHAQ p4@YWHAQ p5@YWHAQ p6@YWHAQ p7@YWHAQ p10@YWHAQ
Sample		p1@YWHAQ	p2@YWHAQ	p3@YWHAQ	p4@YWHAQ	p5@YWHAQ	p6@YWHAQ	p7@YWHAQ	p10@YWHAQ
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	228.31	11.30	0.78	0.39	2.92	1.36	0.97	1.56
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	225.79	13.96	2.02	0.40	1.62	1.42	1.21	2.43
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	249.62	11.96	2.12	0.19	2.89	0.96	0.39	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	181.92	7.48	1.46	0.62	1.66	0.00	1.04	1.25
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	215.29	12.60	1.12	0.45	2.70	0.45	1.12	0.90
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	212.22	10.08	1.94	0.39	4.26	0.19	0.78	1.36
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	276.06	12.42	2.40	0.22	5.45	1.09	1.53	1.31
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	247.55	12.11	2.18	0.97	2.91	0.97	1.21	1.70
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	236.16	9.40	1.71	0.00	2.35	0.21	1.07	1.71
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	150.12	7.54	0.58	1.16	2.90	0.00	0.58	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	145.52	6.47	0.40	0.40	0.40	0.40	0.00	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	177.26	4.47	1.63	0.00	2.03	0.00	0.41	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	109.45	26.76	0.48	1.13	0.00	0.81	0.48	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	103.89	26.46	0.75	0.60	0.00	0.75	1.05	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	90.90	25.25	0.44	0.66	0.44	0.66	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	102.86	25.15	0.75	1.51	0.00	0.25	0.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	83.21	24.02	0.66	0.66	0.22	0.44	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	86.05	18.98	0.42	0.42	0.42	0.84	0.84	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	75.17	18.13	0.00	1.07	0.00	1.07	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	90.57	23.62	0.30	1.35	0.30	0.60	1.50	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	113.60	27.67	0.80	0.80	0.27	0.53	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	109.44	26.41	0.69	1.04	0.17	0.35	0.69	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	101.60	25.59	1.42	0.78	0.39	0.13	0.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	102.89	24.27	1.21	1.21	0.49	0.73	0.73	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	104.49	26.57	0.52	0.26	1.55	0.52	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	106.98	23.11	1.58	1.58	0.63	0.00	0.95	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	92.86	24.73	2.20	0.55	0.00	0.55	1.10	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	113.63	23.10	0.94	0.94	0.00	0.24	1.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	107.90	21.32	1.45	0.16	0.65	0.32	0.48	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	110.39	20.27	1.45	0.54	0.18	0.54	0.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	94.62	21.35	1.05	0.21	0.21	1.26	0.42	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	89.29	20.12	0.39	1.17	0.20	0.20	1.17	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	115.64	28.91	1.48	1.06	0.21	1.48	0.63	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	133.27	26.23	1.65	0.33	0.49	0.99	1.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	99.85	20.38	0.93	0.56	0.93	0.19	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	108.27	21.27	0.57	0.96	0.57	0.38	0.57	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	107.30	17.99	1.43	0.61	0.41	0.61	0.61	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	113.84	21.96	1.01	0.81	0.20	0.40	0.60	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	119.12	23.23	1.35	1.89	0.54	1.08	1.08	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	107.07	22.09	1.44	0.96	0.48	0.72	1.20	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	105.16	18.82	0.47	0.47	0.00	0.47	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	125.61	26.35	1.02	0.44	0.44	0.59	0.88	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	97.43	19.61	0.84	1.05	0.42	0.63	1.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	106.29	22.20	1.22	1.40	0.35	0.70	0.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	116.45	27.71	0.60	0.80	0.40	0.80	1.00	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	108.88	25.36	1.16	1.16	0.70	0.70	2.09	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	100.76	17.99	0.96	0.24	0.24	0.00	0.96	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	98.36	27.42	1.49	0.89	0.60	0.89	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	109.87	18.67	0.24	0.96	0.00	0.48	1.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	94.43	17.19	0.20	0.61	0.81	0.20	0.81	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	86.70	14.14	3.69	1.43	0.41	2.05	1.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	94.51	14.90	1.33	0.44	0.22	1.11	2.89	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	307.83	69.96	55.97	0.00	0.00	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	103.26	15.61	2.48	0.71	1.77	1.06	2.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	98.42	13.92	0.99	0.66	0.66	0.00	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	191.28	31.04	8.39	0.00	1.68	5.03	7.55	2.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	106.54	16.53	1.84	0.46	0.46	3.67	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	91.72	12.64	1.94	1.30	0.32	2.27	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	77.72	8.67	0.96	1.28	0.00	0.64	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	99.33	14.77	2.83	0.94	0.00	1.57	3.46	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	100.12	12.69	2.12	0.71	0.00	0.00	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	86.92	10.09	0.56	0.00	1.12	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	103.50	7.96	6.37	0.00	0.00	3.98	9.55	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	69.99	6.12	2.72	1.02	0.34	1.02	2.38	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	79.28	8.77	0.97	0.65	0.00	0.00	0.97	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	76.32	7.45	2.13	1.42	0.35	0.71	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	452.59	16.16	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	465.95	55.28	7.90	0.00	7.90	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	100.92	13.16	0.98	0.49	0.00	0.98	0.49	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	86.28	8.43	0.99	1.49	0.00	0.50	0.99	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	90.54	11.73	1.41	1.88	0.94	1.88	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	87.43	13.25	1.66	0.99	0.33	0.66	2.65	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	95.28	13.61	1.55	0.62	0.31	2.17	2.78	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	93.25	17.12	0.61	0.31	0.00	0.31	0.92	1.22
Adipocyte - breast, donor1	11376-118A8	158.23	34.37	1.27	1.74	0.48	0.32	0.16	0.16
Adipocyte - breast, donor2	11327-117E4	107.17	27.91	2.73	2.25	0.32	1.28	1.76	0.16
Adipocyte - omental, donor1	11473-119C6	145.17	38.55	0.89	1.27	0.64	0.64	0.13	0.00
Adipocyte - omental, donor2	11474-119C7	105.40	16.44	2.24	2.99	0.75	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	81.05	15.07	1.34	2.68	0.33	1.00	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	108.46	18.50	0.64	1.91	1.28	0.64	3.19	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	43.98	12.09	1.10	0.00	0.00	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	133.68	33.42	1.35	1.35	0.45	0.90	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	69.86	24.15	0.70	1.22	0.35	1.22	0.17	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	151.76	30.90	0.20	1.17	0.00	0.00	0.20	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	97.29	10.81	0.26	0.26	0.00	0.00	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	130.74	30.39	0.28	0.56	0.00	0.56	0.56	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	121.09	23.51	1.76	1.18	0.59	0.59	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	129.18	41.42	0.64	1.85	0.24	0.32	0.16	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	91.66	20.01	1.94	0.32	0.00	0.00	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	108.24	20.79	1.60	0.53	0.00	0.53	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	101.27	31.16	2.23	0.00	0.00	0.00	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	77.36	23.71	0.83	1.66	0.00	0.00	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	85.40	14.07	1.00	0.50	0.25	1.00	0.75	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	99.81	19.63	1.31	1.64	0.65	0.98	0.33	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	78.86	30.45	0.91	1.22	0.30	0.30	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	144.97	15.25	0.22	1.10	0.44	0.00	0.66	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	52.71	2.87	1.08	0.00	0.00	0.36	0.00	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	35.94	7.19	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	311.42	25.19	2.16	0.72	1.08	0.54	0.90	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	199.15	28.45	1.67	1.67	1.67	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	249.82	26.50	1.23	0.82	1.64	1.03	0.82	0.21
Anulus Pulposus Cell, donor1	11248-116E6	196.35	48.52	1.03	1.14	0.11	0.57	0.34	0.11
Anulus Pulposus Cell, donor2	11463-119B5	92.82	32.33	0.73	1.47	0.49	1.22	0.49	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	148.27	24.26	2.25	0.90	0.90	0.90	0.45	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	181.04	24.75	0.87	3.04	0.00	1.30	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	134.84	12.84	12.84	0.00	0.00	0.00	4.28	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	166.50	25.11	5.38	1.49	0.30	1.79	0.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	164.40	34.15	3.79	0.00	0.00	5.06	2.53	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	120.79	20.46	3.96	0.00	0.00	1.32	1.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	157.24	22.74	2.60	2.27	0.65	1.95	0.00	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	161.65	27.67	0.49	0.00	0.49	0.97	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	142.53	28.51	4.16	1.78	0.59	1.19	2.97	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	177.40	19.21	4.52	0.38	0.75	2.26	0.75	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	171.98	21.77	0.73	0.73	0.73	2.90	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	97.79	32.60	5.02	1.25	0.00	1.25	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	176.76	36.24	0.49	0.99	0.33	0.49	0.49	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	136.48	19.11	2.73	0.00	2.73	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	119.58	23.98	0.45	0.30	0.30	0.45	0.30	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	177.88	19.82	2.68	2.68	0.54	1.07	1.61	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	185.72	22.86	2.65	0.76	0.76	2.08	1.13	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	144.87	29.13	2.14	0.00	0.27	1.87	2.14	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	142.42	22.44	1.95	0.98	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	165.53	30.68	2.16	1.00	0.00	2.49	0.50	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	111.67	24.01	2.40	1.20	0.00	2.40	4.80	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	74.34	10.62	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	166.38	29.16	1.03	0.69	0.34	0.69	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	100.68	46.14	0.00	0.00	4.19	0.00	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	171.35	23.30	2.91	1.46	0.00	2.43	1.46	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	168.10	33.39	1.90	1.52	0.38	2.28	1.52	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	157.48	25.44	4.85	1.21	0.00	1.21	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	148.21	22.80	2.28	1.14	0.57	0.57	1.14	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	159.05	27.79	3.63	0.21	1.07	1.71	0.64	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	112.79	22.45	2.32	1.03	0.77	0.52	0.52	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	156.71	24.87	0.47	1.88	0.47	1.88	1.41	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	145.02	25.72	2.25	0.64	0.64	2.25	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	121.29	24.97	2.14	0.71	0.71	1.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	157.35	16.38	1.75	1.17	0.00	1.17	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	143.31	23.48	0.90	0.60	0.60	0.90	0.30	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	134.24	28.51	2.38	0.00	0.00	4.75	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	163.25	23.39	6.10	1.53	0.51	4.07	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	156.63	27.25	5.09	1.27	0.25	3.06	3.31	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	114.37	21.60	3.81	0.00	0.00	0.64	1.91	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	166.14	21.58	3.02	0.43	0.00	1.29	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	143.95	28.79	2.96	0.64	1.27	0.42	0.64	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	114.25	20.01	3.48	1.16	0.00	0.29	0.58	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	136.99	25.51	1.89	0.94	0.00	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	173.93	28.99	2.54	0.51	0.00	0.51	0.34	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	113.50	16.21	2.32	2.32	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	135.20	23.24	6.34	0.00	2.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	170.03	28.52	2.36	1.07	0.00	0.86	0.43	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	111.91	23.46	2.41	1.80	0.60	1.20	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	136.32	18.95	6.56	2.19	0.73	0.73	1.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	160.92	29.65	2.76	0.23	0.23	1.61	1.84	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	109.66	22.95	5.10	5.10	0.00	2.55	7.65	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	135.51	27.71	0.76	0.51	0.25	0.51	0.76	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	164.12	27.87	1.24	1.24	0.83	1.86	0.21	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	125.46	23.87	2.14	1.53	0.92	0.61	0.92	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	162.52	22.94	3.35	0.96	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	133.04	25.28	1.33	1.11	1.11	0.67	1.11	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	109.86	16.78	1.53	0.00	0.00	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	151.77	18.83	1.11	1.66	0.55	0.55	1.11	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	141.40	23.04	1.32	0.00	0.53	0.53	0.79	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	125.75	16.36	2.18	0.36	0.36	2.54	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	158.68	13.51	0.25	0.49	0.49	0.25	0.25	0.25
Astrocyte - cerebellum, donor2	11580-120F5	100.98	7.70	0.51	0.51	1.03	0.68	0.51	0.17
Astrocyte - cerebellum, donor3	11661-122F5	76.35	5.66	0.63	0.21	0.42	0.00	0.00	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	392.86	70.76	1.39	1.05	0.00	1.05	0.70	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	466.23	79.11	4.85	0.97	3.24	2.75	2.26	0.65
Astrocyte - cerebral cortex, donor3	11392-118C6	389.61	60.56	2.68	0.60	1.49	2.09	0.89	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	191.18	28.21	1.49	0.80	0.92	0.92	0.80	0.57
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	206.46	30.44	1.25	0.88	1.88	0.75	0.75	0.88
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	203.35	30.50	1.14	0.91	0.68	0.57	0.91	0.23
Basophils, donor1	12241-129G9	100.69	7.58	0.52	0.26	0.00	0.52	0.00	0.00
Basophils, donor2	12242-129H1	192.66	20.20	0.36	0.36	0.72	0.72	0.36	0.36
Basophils, donor3	12243-129H2	104.96	11.17	0.00	0.29	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	85.81	27.17	0.43	0.43	0.65	0.43	0.22	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	42.06	7.77	0.00	0.00	0.46	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	121.95	21.52	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	97.91	15.06	0.63	0.00	1.26	0.63	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	92.33	13.52	0.21	0.21	0.00	0.62	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	86.13	18.42	1.15	0.69	0.69	0.69	0.69	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	128.48	40.85	1.44	0.54	0.90	1.98	0.54	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	210.54	27.62	0.52	1.03	0.31	0.62	0.41	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	231.04	36.80	0.70	0.93	0.47	0.23	0.93	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	342.80	9.91	0.96	0.96	0.00	0.64	0.64	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	486.07	20.68	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	126.24	16.34	0.00	0.00	1.13	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	118.23	12.62	1.67	0.37	1.11	0.74	0.56	0.19
CD14+ Monocytes, donor3	11381-118B4	99.45	12.29	1.10	0.22	0.44	0.66	0.22	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	61.99	14.72	0.28	0.28	0.00	0.00	0.28	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	72.78	8.72	0.00	1.90	0.00	0.00	0.00	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	64.76	12.16	0.33	0.66	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	55.80	9.11	0.58	1.45	0.00	0.58	0.72	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	58.84	6.03	0.60	1.21	0.00	0.30	0.60	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	62.54	4.97	0.24	0.71	0.24	0.24	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	50.55	5.36	0.50	0.17	0.00	0.33	0.33	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	61.55	5.52	0.00	0.28	0.00	0.28	0.83	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	86.03	5.95	0.50	0.25	0.25	0.50	0.25	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	61.87	7.24	0.59	0.59	0.00	0.20	0.20	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	58.93	9.08	0.00	0.89	0.00	0.36	0.18	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	87.70	6.75	0.87	1.09	0.00	0.87	0.44	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	74.22	8.19	0.23	0.70	0.00	0.23	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	101.91	4.22	1.58	0.53	0.00	1.06	1.58	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	97.62	6.66	0.00	1.11	0.00	0.00	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	61.88	5.80	0.59	1.04	0.00	0.59	0.89	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	53.88	4.79	0.40	0.40	0.20	0.60	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	74.54	5.62	0.21	0.00	0.21	0.00	0.42	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	78.47	8.69	0.46	0.92	0.23	0.00	0.92	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	71.48	7.46	0.45	0.90	0.23	0.45	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	78.13	5.24	0.44	0.00	0.00	0.00	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	59.72	5.65	0.27	0.54	0.27	0.54	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	71.35	9.94	0.52	0.17	0.17	0.17	0.17	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	71.54	5.05	0.84	0.84	0.00	0.84	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	69.26	6.80	0.55	0.73	0.00	0.73	0.55	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	76.44	4.58	0.00	1.06	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	70.63	3.07	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	65.04	7.50	0.17	0.17	0.17	0.35	0.52	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	71.36	8.18	0.74	0.37	0.37	0.00	1.12	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	87.51	8.41	1.08	0.65	0.00	0.43	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	67.57	4.91	0.82	0.41	0.00	0.41	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	68.84	4.40	0.46	0.00	0.23	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	73.31	3.48	0.46	0.00	0.23	0.46	0.46	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	93.29	6.54	0.65	0.65	0.00	0.22	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	87.32	10.16	0.46	0.23	0.23	0.46	0.46	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	90.55	9.96	0.22	0.65	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	91.88	16.20	0.47	0.31	0.00	0.31	0.16	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	77.89	9.26	0.35	0.35	0.00	0.17	0.17	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	83.84	11.37	0.22	1.11	0.00	0.22	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	90.59	9.70	0.00	0.77	0.26	0.26	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	100.34	10.10	0.66	0.88	0.00	0.44	0.44	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	99.59	9.47	0.00	0.42	0.00	0.63	0.42	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	138.20	8.13	2.03	0.00	0.00	2.03	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	145.77	12.88	1.36	0.68	0.00	0.68	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	142.91	6.21	0.00	1.04	0.00	1.04	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	131.13	9.59	0.00	0.00	0.00	0.00	0.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	167.25	12.33	0.00	0.54	0.00	0.54	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	138.98	9.13	0.00	0.00	0.70	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	130.20	8.63	0.00	1.57	0.00	0.78	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	138.42	6.59	1.32	1.32	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	162.74	9.86	1.64	0.00	0.00	0.82	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	139.28	10.88	0.73	0.73	0.00	0.00	1.45	0.00
CD19+ B Cells, donor3	11705-123B4	135.80	8.58	0.50	0.00	0.00	0.50	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	215.77	13.74	1.62	0.81	0.00	0.40	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	176.18	11.19	0.80	1.60	0.00	0.80	0.80	0.00
CD34+ Progenitors, donor1	11545-120B6	160.65	7.03	1.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	138.77	9.55	1.12	0.56	0.56	0.56	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	233.72	13.53	0.75	1.50	0.00	1.13	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	292.00	11.73	0.23	0.90	0.00	0.00	0.00	0.23
CD4+ T Cells, donor1	11225-116C1	146.39	11.78	0.36	0.00	0.36	0.36	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	163.50	17.76	0.61	1.22	0.00	0.61	0.61	0.00
CD4+ T Cells, donor3	11382-118B5	170.49	21.65	0.91	0.00	0.91	0.00	0.91	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	62.28	11.74	0.00	0.00	0.26	0.51	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	62.44	13.25	0.22	0.22	0.00	0.22	0.00	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	48.87	11.50	0.29	0.57	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	132.75	6.64	0.47	0.00	0.00	0.47	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	135.55	9.13	0.00	0.00	0.00	1.40	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	138.44	6.59	0.00	0.00	0.00	3.30	6.59	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	99.86	21.39	1.16	0.87	0.00	0.43	0.87	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	85.07	21.01	0.34	0.85	0.00	0.51	0.68	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	67.55	19.99	0.97	0.81	0.00	0.16	0.32	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	167.66	21.52	2.24	0.45	0.00	0.45	0.90	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	175.39	22.36	0.70	0.35	0.35	0.00	0.35	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	122.31	18.48	0.44	0.00	0.00	0.88	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	71.68	12.65	0.42	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	67.53	9.97	0.42	0.62	0.00	0.21	0.21	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	59.47	8.69	0.67	0.67	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	99.53	12.51	0.54	0.54	0.00	0.27	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	118.98	10.18	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	111.18	7.17	1.79	0.00	0.00	0.00	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	162.44	27.07	0.74	0.74	0.19	0.56	0.37	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	130.40	28.38	0.43	1.08	0.00	1.08	0.22	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	146.27	33.62	1.47	0.00	0.63	0.63	0.21	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	235.61	36.40	1.01	0.51	0.00	0.51	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	218.79	31.19	0.87	0.87	0.43	1.30	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	182.61	21.79	0.44	0.44	0.44	1.31	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	206.36	34.15	0.99	0.49	0.49	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	205.87	28.62	0.92	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	213.56	23.73	1.40	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	128.22	21.32	0.55	0.55	0.28	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	137.42	19.63	0.98	0.98	0.00	0.25	0.49	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	192.50	23.10	0.00	0.00	0.00	0.00	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	191.59	31.16	0.72	0.72	0.36	0.36	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	293.62	40.16	1.38	4.15	0.00	0.00	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	279.60	22.92	0.65	1.31	0.65	0.98	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	271.81	22.15	2.25	0.75	1.50	2.63	0.75	0.00
CD8+ T Cells, donor3	11383-118B6	209.82	15.91	1.01	1.01	1.01	1.26	0.50	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	345.00	13.76	3.67	0.23	2.06	1.61	0.92	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	302.91	11.74	3.12	0.72	0.72	1.20	2.16	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	277.97	14.23	4.10	0.27	1.37	1.09	1.92	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	448.22	12.31	3.30	0.60	3.30	2.10	1.80	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	404.13	12.24	4.56	0.48	3.60	0.96	1.92	0.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	365.86	12.96	1.59	0.00	3.64	0.68	0.91	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	362.00	11.30	3.04	0.65	3.26	0.87	0.65	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	322.16	11.58	2.63	0.26	4.47	0.26	1.05	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	378.98	12.66	3.52	0.47	4.22	2.58	2.11	1.17
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	383.69	16.91	4.83	0.60	2.11	1.51	3.32	1.21
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	319.26	16.85	4.94	0.58	3.49	2.32	2.61	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	403.38	17.58	3.20	0.80	1.33	1.33	1.33	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	278.85	14.45	1.31	0.44	1.75	0.00	0.00	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	322.90	10.02	0.91	0.46	0.91	0.91	0.46	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	236.44	8.95	0.00	0.00	1.49	1.49	0.75	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	365.20	17.29	0.72	0.00	2.88	1.80	2.16	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	336.35	9.21	2.88	0.00	2.59	0.86	1.44	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	299.33	11.08	0.00	0.00	1.89	0.24	0.71	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	470.92	14.58	2.54	0.00	4.12	1.90	0.95	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	385.68	16.30	2.15	0.92	3.08	1.54	0.92	1.23
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	385.98	9.30	2.24	0.64	1.92	0.64	1.28	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	330.07	9.18	4.97	0.38	1.15	1.53	0.00	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	318.44	11.82	1.18	0.79	2.76	1.97	0.79	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	258.69	10.59	3.03	1.51	1.51	0.76	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	249.72	15.26	0.80	0.00	4.01	0.80	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	242.70	15.39	1.40	0.70	2.10	0.70	0.70	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	315.55	19.03	1.00	1.00	1.00	1.00	1.00	1.00
Cardiac Myocyte, donor1	11525-119I4	78.59	20.11	0.00	0.00	0.00	0.00	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	186.27	14.82	0.00	0.49	0.00	1.48	0.99	0.49
Cardiac Myocyte, donor3	11686-122I3	152.27	22.10	0.21	0.84	0.11	0.11	0.00	0.32
Chondrocyte - de diff, donor1	11261-116G1	141.44	18.03	1.39	2.43	0.35	1.04	0.69	0.00
Chondrocyte - de diff, donor2	11338-117F6	118.70	20.97	0.36	0.36	0.00	0.36	0.36	0.00
Chondrocyte - de diff, donor3	11410-118E6	143.82	28.44	3.64	1.37	0.34	1.37	0.91	0.00
Chondrocyte - re diff, donor2	11339-117F7	217.55	22.38	0.00	0.90	0.00	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	156.91	14.56	0.40	0.40	0.00	1.21	0.81	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	306.06	46.13	1.49	0.46	3.79	0.92	1.03	0.69
Ciliary Epithelial Cells, donor2	11323-117D9	240.49	33.99	1.92	1.28	3.85	1.92	1.07	0.64
Ciliary Epithelial Cells, donor3	11399-118D4	220.01	33.98	1.86	0.53	1.59	0.71	1.15	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	200.18	13.66	1.47	0.92	0.83	0.55	0.18	0.18
Corneal Epithelial Cells, donor1	11526-119I5	74.87	12.08	0.44	0.22	0.88	0.44	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	118.31	15.93	3.41	0.00	0.00	0.00	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	119.38	20.96	1.28	0.77	1.02	0.77	0.51	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	80.07	14.86	0.33	1.65	0.50	0.50	0.17	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	85.48	18.29	0.00	1.89	0.32	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	82.82	10.35	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	67.71	9.61	0.54	1.51	0.22	0.65	0.22	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	86.44	7.86	0.34	0.34	0.00	0.00	0.34	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	102.50	15.02	0.00	1.31	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	57.11	3.87	0.48	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	211.46	28.85	0.33	0.50	0.33	0.50	0.50	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	178.38	25.23	1.17	0.00	1.17	0.59	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	167.13	17.53	0.28	0.28	0.57	0.00	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	140.37	27.52	1.18	0.39	0.79	0.00	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	112.57	17.74	0.58	0.58	0.58	0.58	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	149.40	24.23	1.18	0.71	0.24	0.47	1.18	0.00
Endothelial Cells - Artery, donor3	11413-118E9	159.71	22.09	0.88	0.35	0.18	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	172.89	24.38	1.33	0.22	0.66	0.44	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	178.60	30.43	0.00	0.00	0.61	0.30	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	167.17	18.04	0.28	0.00	0.28	0.28	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	154.81	16.34	1.19	1.19	0.30	0.59	0.30	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	140.58	18.74	1.04	0.00	1.04	0.00	0.52	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	104.78	22.26	0.43	0.99	0.43	0.57	0.43	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	178.45	18.01	0.40	0.40	0.00	0.40	0.00	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	116.88	11.53	1.05	0.00	0.00	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	337.95	31.56	1.49	0.62	0.75	1.37	0.50	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	206.18	19.99	1.09	1.30	0.22	0.22	0.22	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	263.31	26.14	0.98	0.61	0.37	0.37	0.24	0.12
Endothelial Cells - Vein, donor1	11267-116G7	192.24	18.20	1.14	0.00	1.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	158.56	25.84	0.70	0.70	1.40	0.70	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	186.52	29.99	0.94	0.79	0.31	0.47	0.47	0.00
Eosinophils, donor1	12244-129H3	137.22	60.99	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	99.02	13.20	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	67.77	10.70	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	91.62	13.68	0.24	0.00	0.73	0.49	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	31.20	2.08	0.00	0.00	0.00	0.00	0.00	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	211.49	16.27	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	91.54	26.68	1.64	1.23	0.00	0.82	0.82	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	108.39	32.85	4.82	0.88	0.55	2.74	2.52	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	163.59	30.44	2.93	1.19	0.43	1.73	2.60	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	220.24	41.36	1.70	0.73	0.97	1.33	1.33	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	136.74	38.08	0.55	0.55	0.41	0.27	0.41	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	141.43	33.64	1.27	1.27	0.11	0.84	1.48	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	94.07	15.81	0.53	0.79	0.26	0.79	0.53	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	309.94	52.49	2.99	1.66	1.33	2.66	1.33	0.33
Fibroblast - Cardiac, donor1	11268-116G8	198.69	21.32	4.08	0.45	1.36	0.00	0.45	0.45
Fibroblast - Cardiac, donor2	11345-117G4	110.66	16.67	2.27	0.00	0.00	0.76	1.52	0.76
Fibroblast - Cardiac, donor3	11417-118F4	109.77	20.19	0.47	0.63	0.32	0.95	0.32	0.00
Fibroblast - Cardiac, donor4	11452-119A3	153.37	32.74	0.30	1.52	0.30	0.30	0.30	0.30
Fibroblast - Cardiac, donor5	11456-119A7	152.16	25.25	1.14	0.51	0.63	1.14	0.00	0.00
Fibroblast - Cardiac, donor6	11460-119B2	161.60	20.31	1.36	1.06	0.30	1.36	0.76	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	99.02	13.00	0.13	0.54	0.94	0.40	0.13	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	94.05	18.98	1.29	0.43	0.00	1.73	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	287.10	29.30	2.93	0.00	4.39	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	111.17	9.46	0.69	0.00	0.23	0.23	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	159.94	45.96	1.87	1.87	0.00	1.02	0.17	0.00
Fibroblast - Dermal, donor1	11269-116G9	168.81	46.49	0.70	2.11	0.47	0.70	0.47	1.41
Fibroblast - Dermal, donor2	11346-117G5	218.39	33.02	0.00	1.42	1.42	0.47	0.47	0.94
Fibroblast - Dermal, donor3	11418-118F5	177.82	61.77	2.78	1.69	0.85	1.21	0.73	0.36
Fibroblast - Dermal, donor4	11450-119A1	263.62	35.95	2.60	0.79	0.68	1.81	1.47	0.34
Fibroblast - Dermal, donor5	11454-119A5	270.23	34.19	1.40	0.70	0.52	2.79	0.52	0.52
Fibroblast - Dermal, donor6	11458-119A9	301.46	34.27	2.44	0.65	0.97	2.11	0.81	0.81
Fibroblast - Gingival, donor1	11237-116D4	184.08	58.93	0.62	1.25	0.21	0.00	0.62	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	204.36	48.21	1.31	1.57	0.52	1.83	1.31	0.00
Fibroblast - Gingival, donor2	11318-117D4	292.16	35.32	2.77	0.79	0.40	1.84	1.19	0.53
Fibroblast - Gingival, donor3	11394-118C8	157.31	60.14	0.97	1.16	0.19	0.39	0.39	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	125.71	20.78	0.00	2.08	0.00	2.08	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	114.53	18.15	1.76	0.35	0.18	0.70	2.11	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	315.69	36.48	2.03	1.40	0.31	1.25	1.40	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	277.49	44.90	3.52	0.81	0.41	0.95	1.49	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	150.68	21.53	0.00	3.53	0.00	0.00	0.35	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	232.24	37.44	1.02	1.02	0.44	1.46	1.90	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	317.70	50.45	3.55	0.55	1.09	1.23	1.64	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	286.19	30.60	3.07	0.66	0.66	1.86	1.21	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	141.75	28.03	1.76	0.73	0.15	0.88	1.03	0.00
Fibroblast - Lung, donor1	11270-116H1	126.42	25.83	1.36	1.36	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	214.87	62.67	0.00	1.49	1.49	0.00	2.98	1.49
Fibroblast - Lung, donor3	11419-118F6	254.51	47.06	2.53	2.32	0.84	0.21	0.63	0.84
Fibroblast - Lymphatic, donor1	11506-119G3	116.62	10.83	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	47.55	18.18	0.00	0.00	1.40	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	39.18	6.16	0.00	0.28	0.00	0.00	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	193.24	24.36	0.00	0.41	0.81	0.00	0.00	0.81
Fibroblast - Mammary, donor2	11620-122A9	59.91	7.99	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	65.52	17.87	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	304.54	38.21	1.75	0.19	0.78	0.97	0.78	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	345.08	37.31	2.12	0.91	0.76	0.76	1.21	0.91
Fibroblast - Periodontal Ligament, donor3	11395-118C9	279.37	52.94	0.00	1.22	0.00	0.61	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	206.46	23.66	1.91	0.38	0.38	0.38	1.14	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	184.94	35.64	2.16	1.35	0.00	1.35	2.16	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	116.55	19.25	0.58	0.93	0.46	0.23	0.58	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	255.33	32.94	1.88	1.11	0.55	1.44	0.33	0.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	116.23	9.96	1.02	1.22	0.41	0.41	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	113.59	12.03	0.00	0.00	1.34	1.34	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	186.61	32.81	0.40	0.79	0.00	0.40	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	171.86	18.85	0.79	0.40	0.00	0.20	1.19	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	115.27	13.68	1.07	0.71	0.18	0.36	0.53	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	154.51	21.29	0.59	0.59	0.59	0.79	0.20	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	210.90	21.66	0.90	0.00	0.30	0.30	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	207.48	26.77	1.84	0.76	0.32	1.40	0.32	0.54
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	114.14	18.73	1.01	0.00	0.25	0.00	0.51	0.00
Fibroblast - skin normal, donor1	11553-120C5	159.32	25.43	0.98	1.15	0.00	0.49	0.66	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	233.79	38.30	1.40	0.80	1.40	0.20	0.20	0.40
Fibroblast - skin normal, donor2	11561-120D4	240.81	27.02	1.91	0.90	0.50	1.51	0.70	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	216.10	28.41	0.91	0.00	0.60	1.21	0.91	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	150.70	24.19	0.83	0.66	0.33	0.17	0.50	0.25
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	131.97	19.32	1.37	0.85	0.17	0.85	0.51	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	154.03	23.98	1.97	0.66	0.00	0.00	0.66	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	307.74	41.44	2.13	1.92	1.07	1.07	0.32	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	299.41	32.05	1.18	1.18	0.34	0.34	0.67	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	146.16	30.42	3.29	1.10	0.47	2.20	2.82	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	1351.75	66.48	22.16	0.00	0.00	0.00	110.80	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	108.07	62.75	2.61	4.36	0.87	1.74	0.87	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	230.05	51.14	1.21	1.21	0.52	0.69	0.87	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	201.17	44.24	0.52	1.30	0.52	0.78	1.30	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	213.86	35.52	0.00	1.53	0.00	0.51	0.26	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	216.65	61.24	4.59	1.53	3.83	0.00	3.83	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	301.17	75.29	3.83	0.00	5.10	0.64	0.00	1.91
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	213.09	55.63	3.99	0.29	6.56	2.57	2.28	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	145.60	42.74	0.28	0.83	1.10	0.28	2.21	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	160.06	29.23	2.51	0.23	1.37	1.83	2.51	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	172.57	40.22	2.58	0.99	2.97	1.39	2.58	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	148.56	32.78	1.85	0.26	1.06	1.59	1.06	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	168.94	35.22	1.63	1.63	1.63	1.30	1.30	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	142.84	54.84	4.86	0.44	3.98	1.33	3.98	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	219.05	32.50	3.39	0.28	1.98	1.55	1.70	0.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	235.45	36.08	2.22	0.25	3.20	0.99	0.62	0.62
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	212.75	41.10	3.49	0.54	2.69	1.07	1.61	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	284.96	33.95	2.97	0.37	1.61	0.87	1.73	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	289.45	35.71	2.91	0.28	2.77	1.38	1.66	0.97
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	209.40	35.78	2.24	0.20	2.64	1.42	1.22	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	223.62	32.17	0.68	0.46	2.28	1.14	0.46	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	225.96	31.89	3.11	0.00	1.87	2.37	1.99	0.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	176.39	31.04	1.97	0.87	1.53	0.22	0.66	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	238.75	22.46	3.84	0.00	0.89	1.48	0.89	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	263.23	19.71	3.18	0.16	0.79	1.59	1.43	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	196.16	24.35	0.45	0.67	1.12	0.67	0.45	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	270.79	22.18	3.83	0.00	1.61	1.21	0.81	1.41
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	314.69	24.43	4.75	0.51	1.02	2.37	2.37	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	233.21	28.20	0.80	0.44	2.04	0.27	0.35	0.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	245.47	26.74	0.31	0.31	1.77	0.10	0.10	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	212.10	20.32	0.34	0.34	0.85	1.02	0.68	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	260.37	24.23	1.99	0.33	0.89	1.33	0.77	0.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	212.57	20.80	0.42	0.58	0.92	0.50	0.42	0.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	215.21	18.99	0.41	0.00	1.43	0.20	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	253.55	22.28	1.65	0.41	1.44	1.03	1.24	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	257.68	20.52	2.31	0.00	1.50	0.92	0.81	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	213.13	16.84	0.83	0.17	0.50	0.67	0.67	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	203.68	26.89	1.32	0.00	2.42	0.88	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	263.08	21.03	3.32	0.49	1.23	2.21	1.97	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	213.15	15.72	0.65	0.16	0.65	1.13	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	196.60	29.51	2.57	0.32	1.60	0.96	0.64	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	245.51	20.94	2.46	0.09	1.52	1.14	0.66	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	163.08	14.71	0.79	0.00	0.16	0.47	1.11	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	217.73	24.02	1.52	0.00	1.52	1.22	0.91	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	276.50	20.70	3.35	0.42	0.73	1.36	1.78	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	166.20	18.66	1.10	0.88	0.00	0.22	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	244.08	22.72	1.40	0.56	1.12	0.56	1.40	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	231.10	16.20	0.46	0.74	0.83	0.46	1.48	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	182.64	20.32	1.34	0.00	0.27	0.80	0.80	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	238.84	22.80	2.14	0.61	0.77	1.07	0.92	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	216.72	19.04	2.20	0.26	0.91	1.81	1.30	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	182.16	16.26	0.27	0.00	0.54	0.27	0.81	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	225.46	24.89	1.84	0.18	0.92	0.74	0.00	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	202.86	19.08	1.32	0.00	1.10	1.32	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	153.72	20.83	0.00	0.99	0.99	0.00	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	217.66	20.45	1.71	0.66	0.66	0.13	0.26	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	174.92	18.16	0.81	0.61	0.20	0.61	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	261.28	26.43	0.00	0.25	0.76	0.25	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	205.63	51.76	3.18	0.60	3.58	1.59	1.00	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	203.07	29.74	1.69	0.15	2.93	2.00	0.92	0.46
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	256.34	65.47	1.64	0.82	6.34	2.45	2.05	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	205.60	66.03	0.94	1.25	6.88	0.94	0.31	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	212.48	74.31	1.41	0.00	3.67	0.57	1.13	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	198.32	63.19	1.84	0.00	4.15	0.92	0.46	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	210.36	56.92	4.95	2.47	0.00	0.00	0.00	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	257.23	50.29	3.87	1.16	5.03	3.48	3.09	1.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	263.13	38.51	4.81	0.00	4.81	0.00	1.60	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	226.05	39.99	1.74	0.00	1.74	0.00	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	244.11	35.15	6.84	0.33	2.93	2.60	1.95	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	239.26	42.00	7.00	0.41	6.59	3.71	2.06	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	239.92	43.32	6.66	0.00	3.33	6.66	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	222.32	33.00	1.12	0.28	3.64	3.08	2.80	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	226.83	25.82	2.29	0.65	7.52	1.31	1.63	1.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	213.06	34.39	3.36	0.00	0.84	2.52	2.52	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	250.00	31.81	2.86	0.32	3.18	1.91	1.59	1.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	235.39	25.13	6.45	0.00	4.76	1.02	0.68	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	250.58	35.50	0.00	0.00	10.44	4.18	2.09	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	281.20	31.50	1.15	0.57	2.29	0.57	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	200.38	20.72	4.44	0.30	0.89	1.78	1.18	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	264.29	32.19	5.08	0.00	1.69	10.16	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	377.34	27.75	5.80	0.00	2.49	4.97	5.38	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	315.28	26.69	2.53	0.46	2.30	2.07	1.61	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	310.84	31.61	10.54	0.00	10.54	5.27	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	264.86	20.76	5.00	0.38	0.77	0.77	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	236.00	17.93	4.24	0.33	0.98	1.96	1.96	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	185.94	20.73	4.01	0.00	2.01	0.00	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	268.92	18.88	4.24	0.00	0.77	2.31	4.62	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	277.30	18.14	4.11	0.68	1.37	2.74	1.71	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	193.81	27.33	2.48	0.00	2.48	9.94	4.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	171.75	17.46	3.77	0.00	0.47	1.89	3.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	246.83	19.92	4.22	0.00	0.60	2.41	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	206.01	28.99	4.07	0.51	2.03	2.54	2.03	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	241.70	17.15	4.79	1.60	2.39	2.79	2.39	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	213.13	12.33	3.45	0.00	0.49	2.47	0.99	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	180.61	8.26	5.90	0.00	2.36	8.26	2.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	205.96	16.92	1.17	0.00	1.17	2.92	1.75	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	173.80	22.82	3.51	0.44	1.32	1.32	0.88	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	176.32	11.02	5.93	0.00	2.54	6.78	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	213.10	13.73	4.18	0.60	0.00	3.58	1.79	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	260.58	8.73	5.82	0.00	0.49	3.88	1.94	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	131.25	15.98	0.00	0.00	0.00	1.14	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	127.24	21.62	1.66	0.83	0.42	0.42	2.08	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	237.26	53.97	4.50	0.00	1.12	0.00	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	80.24	16.18	2.22	0.95	0.63	1.59	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	91.90	32.58	1.67	0.84	0.00	0.84	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	222.57	22.40	2.20	1.28	1.04	0.93	1.97	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	256.41	20.59	2.87	1.52	1.18	0.84	0.68	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	217.49	23.66	1.59	2.28	1.14	1.14	0.23	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	232.50	19.68	1.86	0.66	1.53	1.31	1.64	0.33
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	238.12	18.27	2.15	1.29	1.50	0.86	0.64	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	205.38	16.36	1.29	1.72	0.86	0.22	0.65	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	234.26	18.56	3.49	1.12	1.00	1.25	1.49	0.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	219.24	18.01	2.23	0.69	1.37	1.03	1.37	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	188.70	16.98	1.92	0.64	0.00	1.28	1.28	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	82.82	7.83	0.00	0.56	0.00	0.56	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	74.87	7.36	0.00	0.43	0.43	0.43	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	174.49	13.22	5.29	2.64	0.00	2.64	0.00	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	101.23	11.64	0.35	0.35	0.00	0.35	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	63.21	7.27	0.00	0.00	0.00	0.00	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	239.35	21.51	3.85	0.70	0.70	1.57	1.22	0.35
Hepatocyte, donor1	11523-119I2	71.43	12.11	0.00	1.21	0.00	1.21	1.21	0.00
Hepatocyte, donor2	11603-120I1	91.57	5.39	0.00	1.08	0.00	0.00	1.08	1.08
Hepatocyte, donor3	11684-122I1	87.12	7.98	0.61	0.61	0.00	0.61	1.23	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	240.19	16.97	1.31	0.00	0.00	3.26	1.96	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	218.13	20.62	1.40	0.87	1.22	1.05	0.17	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	163.69	35.12	0.27	0.82	0.82	1.23	0.27	0.41
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	31.84	6.37	0.00	0.00	3.18	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	53.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	73.37	2.77	0.00	0.00	1.38	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	50.05	5.01	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	71.21	0.00	0.00	0.00	0.00	11.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	64.07	2.56	2.56	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	50.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	84.47	8.12	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	66.69	13.34	1.67	0.00	0.00	1.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	54.46	3.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	70.14	10.59	1.32	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	57.65	5.54	0.00	0.00	2.22	2.22	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	57.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	81.25	7.56	1.89	0.00	0.00	0.00	0.63	2.52
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	68.05	0.00	0.00	0.00	1.55	0.00	0.00	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	76.23	3.88	0.00	0.00	0.65	0.00	0.00	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	67.62	1.61	0.00	0.00	0.00	0.00	0.00	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	59.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	70.89	6.52	1.63	0.00	0.00	0.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	51.64	3.36	0.00	0.00	0.00	0.42	0.00	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	61.08	10.45	0.00	0.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	69.25	6.46	0.00	0.00	0.00	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	92.05	6.61	1.42	0.47	2.36	1.42	1.42	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	52.60	9.98	0.91	0.00	2.72	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	14.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	66.72	12.91	0.00	0.00	1.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	59.71	5.08	1.27	0.00	0.00	1.27	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	67.59	6.38	0.64	0.00	0.00	0.64	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	63.79	3.65	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	79.26	2.14	0.00	0.71	0.00	0.00	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	59.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	88.28	8.64	0.62	0.31	0.31	0.31	0.31	1.23
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	50.92	1.76	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	69.15	6.29	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	67.45	4.87	1.39	0.70	2.09	0.00	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	57.54	8.85	0.00	0.00	0.00	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	71.32	9.73	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	54.06	3.49	3.49	0.00	0.00	0.87	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	58.49	2.25	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	38.33	6.97	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	62.94	5.33	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	59.57	2.77	0.00	0.00	0.00	0.00	0.00	2.77
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	76.94	2.85	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	70.87	0.92	0.00	0.00	0.00	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	42.35	3.03	0.00	0.00	3.03	3.03	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	68.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	45.47	4.23	0.00	0.00	1.06	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	149.90	43.98	0.90	0.33	0.90	0.49	0.16	0.41
Keratinocyte - epidermal, donor2	11349-117G8	84.92	12.88	0.59	0.59	0.00	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	195.94	32.56	2.27	0.66	0.00	1.04	0.85	0.28
Keratinocyte - oral, donor1	11251-116E9	244.29	48.93	1.14	0.45	0.23	1.14	0.57	0.45
Keratocytes, donor1	11527-119I6	107.96	8.94	0.00	0.00	0.00	0.00	0.34	0.69
Keratocytes, donor2	11607-120I5	100.77	21.09	1.17	1.17	0.00	0.00	1.17	0.00
Keratocytes, donor3	11688-122I5	120.34	27.47	0.99	0.00	0.40	1.58	0.79	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	195.61	21.98	0.00	4.40	2.20	0.00	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	202.80	37.76	1.08	0.00	2.16	1.08	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	233.66	61.24	0.81	0.12	1.15	0.23	0.23	0.12
Lens Epithelial Cells, donor3	11690-122I7	125.73	20.79	0.20	0.50	1.01	0.20	0.10	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	142.89	19.80	1.66	0.24	0.59	0.24	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	102.70	15.63	0.00	0.00	0.28	0.28	0.84	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	111.13	12.75	1.10	0.31	0.16	0.47	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	129.05	19.90	0.54	1.61	0.54	0.54	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	110.31	11.98	1.58	0.00	0.63	0.00	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	95.63	10.03	0.86	0.32	0.00	0.65	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	118.60	17.65	1.64	0.41	0.00	0.41	0.82	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	81.16	13.91	0.76	0.00	0.00	0.51	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	89.38	12.39	0.56	0.56	0.14	0.70	1.13	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	100.47	13.84	0.79	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	107.80	16.67	1.16	0.19	0.39	0.39	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	66.47	7.78	0.37	0.19	0.00	0.56	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	125.08	16.38	0.35	0.00	0.35	0.35	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	114.01	12.88	0.95	0.24	0.24	0.00	0.72	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	83.92	10.99	0.82	0.00	0.27	0.55	0.55	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	121.64	17.25	0.62	0.31	0.62	0.31	0.92	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	68.90	9.98	0.31	0.00	0.00	0.31	0.62	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	89.12	12.81	1.46	0.18	0.00	0.37	0.55	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	120.78	14.81	0.99	0.66	0.00	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	77.32	12.30	2.05	0.88	0.88	1.17	0.88	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	63.97	7.72	0.25	0.00	0.25	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	109.60	17.94	2.42	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	107.18	17.77	1.08	0.00	0.81	0.27	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	93.70	11.05	0.91	0.15	0.15	0.91	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	88.65	11.92	1.04	0.00	0.00	0.52	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	120.61	19.47	1.26	0.42	0.42	1.05	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	90.22	9.47	1.50	0.45	0.30	0.75	0.60	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	88.74	15.82	1.38	0.00	0.00	0.00	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	100.85	15.24	0.56	0.38	0.38	0.19	0.75	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	78.89	10.18	0.74	0.21	0.32	0.74	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	109.51	17.93	2.42	0.00	0.48	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	81.37	15.55	0.33	0.33	0.33	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	79.66	10.78	0.87	0.00	0.12	0.50	0.50	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	118.84	14.44	0.00	0.00	0.00	0.74	1.11	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	107.23	13.59	0.25	0.99	0.25	0.74	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	80.43	8.94	1.10	0.27	0.41	0.41	0.27	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	121.58	9.97	0.96	0.64	0.64	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	102.86	24.96	0.91	0.61	0.30	0.91	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	116.87	13.86	0.98	0.70	0.28	0.98	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	119.82	16.00	0.36	0.00	1.42	1.78	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	72.23	12.12	0.48	0.48	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	56.64	7.16	0.47	0.31	0.16	0.62	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	117.46	15.40	0.36	0.36	0.36	0.00	1.43	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	100.62	18.95	0.65	0.33	0.65	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	54.38	4.94	0.24	0.24	0.00	0.24	0.94	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	117.19	18.19	0.99	0.25	0.37	0.74	0.50	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	61.98	15.37	0.51	0.00	0.26	0.26	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	76.08	6.56	0.90	0.00	0.00	0.00	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	217.54	0.00	0.00	0.00	2.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	179.51	6.14	0.00	0.77	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	153.64	5.20	0.00	2.97	0.00	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	156.98	9.31	4.23	0.42	0.85	2.96	1.69	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	130.11	5.63	2.81	1.41	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	123.28	8.41	0.93	2.80	0.00	0.00	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	119.54	7.21	6.18	0.52	1.03	1.03	3.09	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	145.11	13.08	0.00	0.00	2.38	2.38	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	169.42	9.73	0.90	0.90	0.45	0.23	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	146.58	5.23	4.36	1.45	0.58	1.45	2.04	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	165.21	7.65	2.25	0.45	0.90	2.25	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	183.45	8.13	0.00	0.41	0.68	0.68	0.14	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	139.16	8.22	1.54	0.51	0.51	1.54	1.54	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	176.43	7.41	1.41	1.76	0.00	0.71	1.06	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	137.93	4.66	2.00	1.33	1.33	0.00	1.33	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	145.68	6.11	2.55	0.51	0.00	1.02	3.57	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	188.10	7.47	1.87	1.07	0.27	1.33	0.27	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	171.94	3.97	3.40	1.89	0.94	1.89	1.51	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	141.12	6.75	3.07	1.23	0.61	0.61	1.84	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	193.26	8.15	4.08	0.82	0.82	1.63	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	156.81	6.25	2.92	1.67	0.62	1.67	1.87	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	157.51	5.61	5.89	0.84	0.56	1.96	5.04	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	149.40	10.30	1.03	1.03	0.00	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	175.63	7.26	4.94	1.45	0.87	2.03	2.32	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	152.75	9.57	1.79	1.79	0.30	1.79	0.90	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	166.53	6.09	1.11	1.66	1.11	1.66	1.66	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	187.70	6.01	2.83	1.41	0.71	1.77	1.77	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	155.26	5.90	2.95	0.37	0.74	1.84	1.84	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	134.70	8.06	1.15	1.15	0.00	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	168.85	5.37	3.07	0.38	0.38	3.07	0.77	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	155.12	13.59	4.53	0.00	0.57	0.57	1.13	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	186.25	6.56	1.64	0.00	0.82	0.00	1.64	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	168.10	4.97	3.62	1.81	0.45	1.36	1.36	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	135.01	2.15	0.72	0.72	1.44	2.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	163.57	4.48	3.73	1.49	0.75	0.00	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	180.59	9.29	4.46	0.00	0.37	2.23	1.11	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	155.07	6.03	3.45	0.86	1.29	0.43	1.29	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	168.69	7.71	3.43	2.57	0.00	0.00	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	174.25	7.66	3.66	1.33	0.67	1.00	1.67	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	130.92	7.84	3.02	0.00	1.81	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	153.58	3.55	1.42	0.71	0.71	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	166.70	5.50	3.09	1.03	1.03	1.72	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	150.29	5.37	7.51	0.54	0.54	3.22	3.22	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	173.05	6.73	1.35	0.00	0.00	1.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	180.39	7.41	4.07	1.11	0.74	2.96	1.11	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	179.09	10.47	1.16	0.00	0.00	2.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	150.20	7.40	0.00	0.00	0.00	0.00	1.06	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	164.86	4.40	2.00	0.40	0.80	1.20	1.60	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	116.30	5.81	2.18	0.73	0.00	1.45	1.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	190.86	4.60	1.53	0.00	0.00	2.30	1.53	2.30
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	160.81	5.92	3.95	2.47	0.49	2.47	2.47	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	111.03	2.82	1.88	0.94	2.82	0.94	1.88	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	192.08	6.54	1.51	0.50	0.50	2.01	1.01	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	172.59	5.41	3.15	0.00	0.45	1.80	2.25	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	134.25	8.61	5.16	1.72	1.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	187.49	5.79	2.67	0.45	0.45	2.23	3.12	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	146.63	5.87	5.08	0.78	0.78	1.96	1.17	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	120.73	7.92	3.30	1.32	0.00	1.32	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	185.78	4.67	1.04	1.56	0.52	1.56	2.08	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	201.72	4.81	3.06	0.44	0.00	1.75	3.94	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	153.75	5.59	2.24	0.00	0.00	0.56	2.24	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	165.17	6.62	3.09	0.88	0.00	0.00	1.32	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	169.71	5.79	2.70	0.00	0.77	4.63	1.16	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	147.86	7.09	1.01	0.51	0.51	1.52	1.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	171.10	8.65	1.44	1.44	1.44	1.44	0.48	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	170.15	6.76	1.99	0.00	0.40	2.39	1.19	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	133.68	7.29	2.43	0.61	0.61	1.22	1.22	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	104.45	4.15	2.08	0.69	0.00	1.38	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	178.60	4.56	3.42	0.76	1.52	0.76	2.28	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	152.86	5.68	7.75	1.03	1.03	2.07	3.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	113.68	4.23	2.42	1.21	0.00	0.60	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	171.44	5.70	1.90	1.27	0.32	1.58	2.22	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	132.74	8.53	0.53	1.07	0.53	1.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	120.11	4.60	1.72	1.72	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	135.76	1.03	4.63	0.51	0.51	1.54	3.09	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	161.28	6.37	6.37	0.00	1.41	2.12	1.41	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	120.87	2.27	2.27	0.57	0.00	1.13	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	156.43	5.41	5.41	0.42	0.83	1.66	1.66	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	152.69	7.05	3.13	0.78	0.78	2.35	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	121.51	5.85	3.34	0.42	0.00	0.42	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	158.91	8.36	1.86	1.39	0.46	2.32	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	147.19	8.03	1.34	0.67	0.67	0.00	0.67	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	154.51	3.74	2.14	1.07	1.07	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	175.38	8.08	5.66	0.00	1.21	0.40	1.62	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	108.30	5.51	1.84	0.92	0.00	1.84	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	110.25	4.45	0.89	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	172.67	5.70	0.00	0.00	0.00	0.57	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	136.51	5.37	0.77	1.53	0.00	0.00	0.00	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	121.47	5.47	1.64	0.00	1.09	0.55	0.55	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	155.91	5.79	0.89	0.45	1.34	2.23	3.12	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	202.25	8.58	0.52	1.30	1.56	0.00	0.52	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	143.89	2.65	2.65	0.00	1.33	0.66	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	130.95	8.31	4.16	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	49.69	11.17	0.00	0.46	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	74.50	15.41	0.37	1.28	0.55	0.37	0.00	0.18
Macrophage - monocyte derived, donor3	11389-118C3	77.73	14.29	0.79	1.18	0.26	0.39	0.66	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	206.57	53.63	0.00	1.59	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	190.62	28.68	1.43	0.16	0.63	0.79	0.95	0.16
Mallassez-derived cells, donor3	11930-125I4	202.92	37.11	1.67	0.28	0.83	0.69	0.69	0.14
Mammary Epithelial Cell, donor1	11273-116H4	204.97	54.60	0.80	1.49	0.60	0.40	0.50	0.70
Mammary Epithelial Cell, donor2	11350-117G9	236.56	44.30	1.45	0.87	1.16	0.58	0.87	0.00
Mammary Epithelial Cell, donor3	11422-118F9	194.05	26.69	0.50	0.50	0.25	0.25	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	283.38	30.51	2.03	0.68	5.42	2.03	0.00	0.68
Mast cell, donor1	11563-120D6	127.07	21.74	0.32	1.19	0.22	0.32	0.43	0.00
Mast cell, donor2	11565-120D8	168.79	10.70	0.30	0.00	0.00	0.00	0.89	0.00
Mast cell, donor3	11566-120D9	151.51	8.55	0.68	0.68	0.23	0.00	0.23	0.00
Mast cell, donor4	11567-120E1	165.94	12.59	0.00	1.24	0.53	0.89	0.18	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	131.96	20.85	1.22	0.55	0.89	0.55	0.44	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	74.13	9.92	0.58	0.58	3.50	0.58	0.00	0.58
Mast cell, expanded, donor5	11939-126A4	176.33	24.55	1.38	1.03	0.34	0.46	0.69	0.00
Mast cell, expanded, donor8	11941-126A6	88.70	11.88	0.33	0.84	0.00	0.33	0.33	0.00
Melanocyte - dark, donor1	11502-119F8	147.95	14.33	0.90	0.30	0.00	0.30	0.10	0.10
Melanocyte - dark, donor2	11582-120F7	188.96	20.76	1.38	0.00	0.35	0.00	1.38	0.69
Melanocyte - dark, donor3	11663-122F7	183.06	18.40	0.58	0.14	0.14	0.43	0.22	0.00
Melanocyte - light, donor1	11274-116H5	95.91	13.87	0.24	0.47	0.00	0.24	0.00	0.24
Melanocyte - light, donor2	11351-117H1	71.66	10.92	0.00	0.68	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	78.92	14.74	0.87	0.87	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	185.34	10.20	1.77	0.31	0.10	0.83	1.04	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	154.64	12.10	0.54	0.00	0.27	0.81	0.81	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	137.68	11.25	1.34	0.27	0.27	0.80	0.54	0.00
Meningeal Cells, donor1	11493-119E8	142.54	15.76	0.12	0.12	1.49	0.37	0.12	0.00
Meningeal Cells, donor2	11573-120E7	147.01	11.88	1.32	0.44	0.44	0.88	0.44	0.44
Meningeal Cells, donor3	11654-122E7	261.38	28.20	0.73	0.49	3.42	0.57	0.65	0.73
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	322.51	35.64	1.71	1.43	0.86	2.00	0.29	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	119.55	17.91	0.50	1.01	0.50	0.40	0.30	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	26.28	5.26	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	77.18	10.47	1.31	1.31	0.00	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	202.36	35.88	2.87	0.72	1.44	0.72	0.72	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	91.27	12.07	0.64	0.64	0.21	0.42	0.21	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	102.54	11.06	0.00	0.50	0.50	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	142.40	11.21	0.88	0.00	0.66	0.44	0.22	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	140.27	18.26	1.46	0.00	1.46	1.46	0.73	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	131.36	11.66	1.23	1.02	1.43	0.61	0.82	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	95.29	22.58	0.28	1.25	0.14	0.14	0.00	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	50.93	5.95	0.37	0.00	0.00	0.00	0.37	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	135.78	28.03	0.79	0.53	0.26	0.39	0.39	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	39.17	8.90	0.00	0.59	0.00	0.30	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	18.68	7.01	0.00	0.00	0.00	0.00	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	103.74	7.04	2.56	0.00	0.64	0.00	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	236.41	38.28	1.77	0.00	1.06	0.35	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	145.73	32.21	0.94	0.31	0.31	0.00	0.63	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	222.06	20.32	0.73	1.45	0.00	0.73	0.73	2.18
Mesothelial Cells, donor1	11247-116E5	232.82	39.78	0.27	1.33	0.53	0.80	0.80	0.27
Mesothelial Cells, donor2	12156-128G5	241.22	66.06	1.50	2.00	1.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	173.58	27.17	0.87	1.08	0.43	0.79	1.16	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	75.62	12.15	0.00	1.35	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	73.88	16.75	0.49	0.25	0.25	0.00	0.49	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	65.08	15.61	0.29	0.29	0.29	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	48.40	13.83	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	65.09	10.23	1.55	0.93	0.31	0.00	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	65.55	10.58	0.41	0.62	0.21	0.00	0.83	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	55.59	6.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	78.33	14.77	1.25	1.50	0.25	0.25	1.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	70.29	10.24	0.00	1.86	0.93	0.93	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	77.83	14.23	0.20	0.81	0.61	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	64.15	17.82	0.40	0.79	0.00	0.40	0.00	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	51.31	8.55	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	49.56	13.27	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	69.91	14.82	0.76	1.14	0.76	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	67.11	6.58	0.00	1.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	58.36	9.13	0.21	0.64	0.21	0.21	0.64	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	44.20	8.29	0.00	0.00	0.92	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	60.80	9.24	0.60	0.89	1.19	0.60	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	26.83	18.44	0.00	0.00	3.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	169.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	71.51	11.54	0.50	0.25	0.75	0.25	0.50	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	69.64	13.55	0.48	0.71	0.71	0.00	0.71	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	50.31	10.50	0.00	1.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	74.37	9.90	1.61	1.38	1.61	0.46	0.92	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	68.99	13.88	0.00	0.84	1.05	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	68.49	11.82	0.41	1.02	1.02	0.00	0.41	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	75.52	10.08	0.21	0.86	0.64	0.43	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	77.13	13.34	0.22	0.67	1.33	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	103.18	20.64	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	67.24	7.88	0.66	0.22	0.66	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	52.22	7.60	0.00	0.51	1.01	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	41.42	11.60	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	89.69	11.96	1.36	1.09	1.09	1.09	0.54	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	77.34	17.64	0.29	0.29	0.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	35.98	10.90	0.00	0.00	2.18	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	81.21	6.25	0.00	1.92	0.96	0.00	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	81.25	14.81	1.60	0.40	0.00	0.40	0.80	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	45.25	5.48	0.00	0.00	0.00	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	103.12	13.02	1.00	0.50	1.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	161.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	20.39	2.04	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	84.08	9.20	0.44	0.00	1.75	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	49.66	19.87	0.00	1.10	0.00	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	56.35	8.33	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	96.94	14.63	0.74	0.74	0.25	0.25	0.00	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	64.02	10.44	0.00	2.09	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	61.88	8.84	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	74.19	11.28	0.68	0.68	1.03	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	60.83	13.57	0.88	0.88	1.75	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	50.78	7.46	0.00	0.71	0.36	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	82.76	14.59	0.84	0.28	0.56	0.00	0.00	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	68.16	15.79	0.00	0.42	0.83	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	39.63	7.58	0.00	0.58	0.58	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	86.58	13.27	0.00	0.30	0.30	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	77.63	13.77	0.42	0.42	0.42	0.42	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	50.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	67.42	12.93	0.00	0.00	0.92	0.92	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	81.38	14.23	0.00	0.00	1.71	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	55.41	12.02	0.00	0.28	0.28	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	61.42	18.14	0.00	0.00	0.78	0.52	0.78	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	83.65	13.30	0.43	0.00	0.00	0.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	37.48	6.35	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	56.85	10.94	0.00	0.80	0.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	74.23	15.27	0.00	0.60	0.90	0.30	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	41.10	6.92	0.14	0.14	0.14	0.14	0.14	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	67.52	13.70	0.32	0.00	0.32	0.32	0.00	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	89.56	15.92	0.66	1.33	0.22	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	36.78	8.72	0.76	0.38	0.38	0.00	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	56.82	12.78	0.00	0.28	0.28	0.00	0.57	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	75.95	13.76	0.74	1.47	0.25	0.25	0.74	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	28.02	10.43	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	47.63	14.41	0.59	0.88	0.00	0.29	0.59	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	60.55	14.13	0.58	1.44	0.58	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	47.40	18.13	0.41	0.82	0.82	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	53.30	11.02	0.00	0.30	0.00	0.00	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	37.67	0.00	0.00	0.00	0.00	0.00	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	49.90	5.35	0.00	0.00	0.00	0.00	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	47.64	4.60	0.66	0.99	0.00	0.33	0.66	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	52.60	3.16	1.05	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	43.49	5.34	0.20	0.40	0.00	0.20	0.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	55.88	4.66	0.93	0.93	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	41.31	2.25	0.38	0.00	0.00	0.00	0.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	57.26	8.79	0.00	1.60	0.27	0.80	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	41.51	6.79	0.34	0.68	0.11	0.00	0.23	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	42.73	8.84	0.00	0.00	0.00	0.74	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	40.67	4.76	0.37	0.73	0.00	0.00	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	65.34	10.89	4.67	1.56	0.00	0.00	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	64.13	5.34	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	38.64	7.73	3.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	45.45	4.04	1.01	0.00	0.00	0.00	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	48.07	5.48	0.84	0.00	0.42	0.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	70.82	5.45	1.36	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	61.67	17.17	0.00	0.64	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	75.31	12.15	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	52.87	4.53	0.00	0.00	1.51	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	456.81	0.00	0.00	0.00	5.71	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	234.90	6.52	0.00	3.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	142.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	238.43	0.00	0.00	0.00	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	183.77	29.08	0.86	0.43	1.72	1.08	0.22	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	131.18	9.93	1.05	0.00	0.52	0.00	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	142.84	18.02	0.67	0.67	2.67	0.00	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	109.77	16.69	1.67	1.67	1.25	0.42	0.83	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	174.55	23.20	5.51	2.28	0.57	0.95	4.37	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	272.89	36.70	1.60	0.00	3.19	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	91.11	13.60	0.00	0.00	0.68	0.68	0.68	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	474.11	80.86	7.35	1.84	0.00	1.84	7.35	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	95.43	8.37	0.42	2.09	0.42	0.42	0.84	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	115.29	15.57	0.70	2.32	0.23	0.23	1.39	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	113.50	15.94	1.08	1.08	1.08	0.27	1.08	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	178.70	21.65	1.05	2.10	0.21	0.42	1.26	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	801.70	111.35	11.13	11.13	0.00	0.00	22.27	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	130.05	25.81	1.99	1.49	0.00	1.49	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	66.86	11.64	1.08	0.54	0.27	0.27	0.81	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	69.14	12.47	0.91	2.04	0.91	0.45	0.91	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	80.18	11.76	0.49	0.82	0.33	0.00	0.82	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	151.45	18.04	2.55	0.55	0.73	0.91	0.91	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	77.44	15.91	1.59	0.53	0.53	0.00	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	66.03	15.61	1.20	2.40	0.60	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	74.50	18.38	3.28	1.64	0.00	1.31	1.97	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	53.02	11.22	0.33	0.81	0.16	0.33	0.33	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	136.34	19.23	1.76	0.71	0.18	0.71	0.35	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	56.26	9.85	1.41	2.11	0.00	1.41	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	70.34	9.19	0.46	0.46	0.00	0.00	0.92	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	70.37	9.32	0.96	0.96	0.00	0.32	0.64	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	96.57	20.35	3.79	0.34	0.00	1.72	4.48	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	369.15	85.97	5.06	0.00	5.06	0.00	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	108.72	13.59	0.89	1.11	0.22	0.22	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	52.08	9.74	0.85	0.85	0.00	0.42	0.85	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	58.15	11.87	0.95	1.42	0.00	0.24	1.19	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	84.99	9.87	0.86	0.86	0.00	0.00	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	180.56	0.00	0.00	0.00	0.00	9.03	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	63.98	12.33	0.67	0.33	0.33	0.00	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	79.35	12.17	0.45	0.90	0.45	0.00	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	42.06	9.92	1.19	0.00	0.00	1.19	0.79	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	66.86	7.43	0.93	0.93	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	59.40	8.32	0.00	2.65	0.38	1.14	1.14	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	53.45	8.47	0.98	1.96	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	64.06	9.15	0.87	0.00	0.44	0.00	0.87	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	101.31	11.31	2.26	0.45	0.45	0.45	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	51.15	6.17	0.88	1.76	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	65.15	6.65	0.66	1.33	0.00	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	59.53	7.44	0.99	0.50	0.00	0.50	0.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	51.68	9.95	0.00	1.15	0.00	0.77	0.77	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	68.05	9.68	1.21	0.60	0.00	0.30	0.91	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	100.57	12.38	0.88	0.66	0.22	1.55	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	56.25	4.07	0.68	2.03	0.68	0.00	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	373.00	45.99	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	78.04	11.58	1.83	0.00	0.00	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	45.01	10.07	0.31	1.26	0.00	0.31	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	62.04	6.96	0.30	0.30	0.30	0.00	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	55.38	8.70	0.00	0.79	0.79	0.00	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	124.70	23.81	1.13	0.00	0.00	0.00	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	227.60	45.52	5.06	0.00	0.00	0.00	10.12	0.00
Myoblast, donor1	11241-116D8	165.60	45.34	1.49	0.99	0.75	0.99	0.75	0.12
Myoblast, donor2	11322-117D8	178.94	38.17	4.22	1.73	0.58	1.92	2.11	0.58
Myoblast, donor3	11398-118D3	218.44	43.89	0.50	1.35	0.84	0.50	0.34	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	165.34	20.28	0.44	0.88	0.15	1.02	1.02	0.00
Natural Killer Cells, donor1	11230-116C6	249.09	23.99	0.31	0.00	0.31	0.31	0.92	0.00
Natural Killer Cells, donor2	11311-117C6	228.88	23.82	2.71	0.00	1.81	0.90	1.51	0.00
Natural Killer Cells, donor3	11387-118C1	210.93	22.09	0.92	0.55	1.29	0.92	0.74	0.00
Neural stem cells, donor1	11275-116H6	393.79	56.26	0.73	1.81	3.27	1.45	2.54	0.36
Neural stem cells, donor2	11352-117H2	591.17	57.77	0.00	3.85	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	714.60	45.52	5.69	0.00	1.14	4.55	3.41	0.00
Neurons, donor2	11574-120E8	626.80	68.47	3.52	0.88	2.42	1.10	1.32	0.22
Neurons, donor3	11655-122E8	456.30	29.60	8.22	0.82	2.47	4.93	6.58	1.64
Neutrophils, donor1	11233-116C9	39.90	9.28	0.93	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	37.69	20.29	0.00	2.90	0.00	2.90	0.00	0.00
Neutrophils, donor3	11390-118C4	58.03	11.61	0.61	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	195.32	43.22	1.42	0.71	0.12	0.24	0.12	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	114.29	33.54	0.98	0.33	0.98	0.33	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	103.28	20.66	1.00	0.60	0.00	0.80	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	71.03	16.24	0.28	0.41	0.28	0.00	0.96	0.00
Olfactory epithelial cells, donor2	11934-125I8	110.15	20.55	7.24	0.87	0.43	1.88	3.47	0.29
Olfactory epithelial cells, donor3	11935-125I9	81.72	15.78	0.79	0.57	0.11	0.45	0.68	0.00
Olfactory epithelial cells, donor4	11936-126A1	97.01	27.08	0.58	0.39	0.19	0.68	0.88	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	208.23	22.87	0.60	0.60	0.00	0.60	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	115.92	22.12	0.00	1.28	0.00	0.64	0.21	0.00
Osteoblast - differentiated, donor2	11353-117H3	77.73	9.14	0.00	0.00	0.00	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	89.38	20.48	0.62	0.62	0.00	1.24	0.00	0.00
Osteoblast, donor1	11277-116H8	184.88	21.89	0.59	0.59	0.39	0.20	0.20	0.20
Osteoblast, donor2	11354-117H4	341.33	42.84	0.70	0.00	0.70	0.00	0.70	0.00
Osteoblast, donor3	11426-118G4	286.50	33.95	0.36	1.24	0.71	1.96	0.53	0.89
Pancreatic stromal cells, donor1	11249-116E7	229.63	48.44	3.20	1.10	0.25	1.18	0.67	0.25
Pericytes, donor1	11491-119E6	38.83	5.12	0.00	0.22	0.11	0.00	0.22	0.00
Pericytes, donor2	11571-120E5	30.79	3.40	0.00	0.68	0.68	0.23	0.23	0.00
Pericytes, donor3	11652-122E5	74.06	9.36	1.02	0.81	0.00	0.41	0.61	0.00
Perineurial Cells, donor1	11499-119F5	174.50	28.37	0.79	0.45	1.24	0.57	0.45	0.68
Perineurial Cells, donor2	11579-120F4	205.74	27.97	0.92	0.74	0.28	0.09	0.83	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	115.06	20.08	0.96	0.32	0.00	0.00	0.32	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	88.88	10.77	0.73	0.49	0.24	1.22	0.73	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	115.05	16.31	0.65	1.29	0.26	0.65	0.13	0.00
Placental Epithelial Cells, donor1	11278-116H9	275.52	24.63	1.43	1.43	1.20	0.24	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	182.97	22.18	2.22	0.00	1.11	2.22	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	246.98	25.33	0.59	0.98	0.39	1.57	1.77	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	113.29	28.80	3.80	2.85	0.95	0.63	0.95	0.00
Preadipocyte - breast, donor1	11467-119B9	104.11	33.58	0.75	2.44	0.56	0.19	0.38	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	108.99	22.19	0.13	0.26	0.26	0.26	0.13	0.00
Preadipocyte - breast, donor2	11328-117E5	129.01	31.75	2.03	3.15	0.45	1.80	1.35	0.45
Preadipocyte - omental, donor1	11468-119C1	124.99	33.14	1.07	1.92	0.64	0.32	0.53	0.00
Preadipocyte - omental, donor2	11329-117E6	144.91	29.68	0.00	1.31	0.00	0.00	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	141.82	33.52	0.86	2.15	0.72	1.00	0.86	0.43
Preadipocyte - perirenal, donor1	11469-119C2	100.40	19.69	0.98	0.98	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	162.77	36.85	0.92	0.31	0.61	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	289.88	44.09	2.12	1.06	0.53	1.95	1.59	0.71
Preadipocyte - subcutaneous, donor3	11428-118G6	208.94	47.85	1.36	1.19	0.51	0.68	0.85	0.17
Preadipocyte - visceral, donor1	11280-116I2	268.82	56.91	0.84	1.02	0.65	0.19	0.28	0.56
Preadipocyte - visceral, donor2	11357-117H7	242.98	48.32	5.52	0.46	0.46	0.46	2.76	0.00
Preadipocyte - visceral, donor3	11429-118G7	257.36	43.99	1.36	1.04	0.84	2.40	1.67	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	230.95	24.14	1.36	0.15	1.81	0.75	1.81	0.30
Prostate Epithelial Cells, donor2	11331-117E8	199.60	53.89	4.47	0.95	2.71	1.90	2.84	0.41
Prostate Epithelial Cells, donor3	11404-118D9	116.84	35.58	1.04	1.29	1.10	0.43	0.92	0.37
Prostate Stromal Cells, donor1	11254-116F3	196.93	33.26	1.48	0.23	0.57	0.57	0.46	0.11
Prostate Stromal Cells, donor2	11332-117E9	193.64	26.89	2.51	0.72	1.08	0.90	3.23	0.18
Prostate Stromal Cells, donor3	11405-118E1	121.38	27.42	2.40	1.04	0.31	0.73	1.15	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	105.11	8.76	0.00	0.36	0.73	0.00	0.36	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	223.60	24.81	1.66	0.62	0.49	0.35	0.49	0.21
Renal Epithelial Cells, donor1	11517-119H5	109.05	10.14	0.00	0.00	0.00	0.51	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	125.90	7.11	0.00	0.00	0.00	0.00	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	236.50	29.85	1.06	0.74	0.64	0.32	0.32	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	76.26	6.81	1.36	0.00	0.00	0.00	1.36	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	108.89	13.34	1.35	0.40	0.00	0.54	0.40	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	232.22	21.31	1.55	0.22	0.44	1.11	0.44	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	39.93	3.99	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	120.83	8.36	0.22	0.00	1.10	0.22	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	102.20	7.52	1.25	0.00	0.00	0.63	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	50.21	7.49	0.00	0.00	0.83	0.00	0.55	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	168.57	20.13	0.27	1.34	0.54	0.27	0.00	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	86.87	9.28	0.84	0.42	0.42	0.42	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	149.07	12.15	0.39	0.77	0.58	0.39	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	318.92	24.63	2.07	1.04	1.56	1.04	0.00	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	106.59	7.67	0.00	0.85	0.28	0.28	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	92.62	8.23	0.00	1.03	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	106.38	12.04	0.50	0.50	0.00	0.00	0.50	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	111.85	13.50	0.67	0.67	0.00	0.00	0.27	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	126.86	8.93	0.89	0.89	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	160.71	7.71	2.20	0.00	0.00	1.65	1.65	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	156.03	9.28	1.74	1.16	0.58	0.58	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	217.92	10.01	1.43	0.13	0.65	0.26	0.78	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	249.85	12.81	1.79	0.40	1.19	1.09	1.49	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	277.84	19.07	1.12	0.11	1.34	1.00	0.78	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	308.12	18.98	3.10	0.12	0.87	1.24	1.61	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	271.78	16.55	3.26	0.58	0.82	1.40	1.05	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	295.39	16.87	4.85	0.46	1.16	0.92	1.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	178.94	12.87	2.19	0.27	0.82	0.68	0.82	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	265.18	11.95	2.72	0.45	1.06	2.12	1.66	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	270.58	18.81	0.90	0.36	1.61	0.36	0.90	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	203.42	10.47	1.15	0.29	0.29	1.58	0.43	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	251.33	15.13	2.36	0.54	1.29	1.61	1.07	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	252.03	15.27	2.21	0.44	0.89	1.33	1.11	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	167.66	12.62	1.91	0.38	0.38	0.76	0.76	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	247.53	12.30	0.84	0.56	1.86	1.21	0.56	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	256.12	20.29	0.94	0.94	1.50	0.94	0.75	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	204.90	10.48	2.12	0.40	0.80	0.27	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	283.07	12.46	1.27	0.58	1.46	1.17	0.88	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	268.11	14.70	1.53	0.57	1.34	0.38	0.76	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	212.20	11.64	1.50	0.53	0.53	0.85	0.96	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	253.96	13.45	7.01	0.00	0.84	2.52	3.64	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	266.77	13.84	1.54	0.34	1.37	0.85	1.88	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	178.14	9.66	0.91	0.73	0.18	0.18	0.36	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	252.50	14.72	2.82	0.37	2.08	1.35	0.74	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	296.44	14.24	2.55	0.81	1.48	1.21	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	194.83	12.74	2.83	0.47	0.94	0.94	0.24	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	258.73	10.32	1.98	0.40	1.79	0.99	1.79	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	274.07	15.43	3.51	0.70	2.10	0.00	0.70	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	199.89	10.58	2.70	0.62	0.41	1.04	1.04	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	253.06	12.61	7.30	0.44	0.44	4.65	3.76	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	248.57	13.79	2.09	0.21	1.67	1.04	0.84	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	222.06	9.69	2.29	0.40	0.54	0.94	1.62	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	251.53	12.94	0.68	0.17	0.85	0.17	0.68	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	260.66	13.88	2.31	0.19	0.96	0.58	0.77	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	210.28	15.65	1.55	0.34	1.03	1.03	0.86	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	265.15	15.23	0.82	0.55	1.92	0.55	0.27	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	272.03	16.58	5.58	0.49	1.48	4.43	2.13	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	163.95	12.61	1.87	0.17	0.68	0.85	0.85	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	329.65	20.57	1.33	0.30	1.78	1.63	0.74	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	250.82	14.13	2.40	0.00	0.53	0.27	0.53	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	143.11	8.30	1.24	0.28	0.14	0.69	0.14	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	250.96	18.81	2.38	0.24	1.19	2.38	2.38	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	255.55	17.74	0.60	0.81	1.01	1.21	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	171.96	14.50	1.32	0.19	0.57	0.66	0.47	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	231.98	11.53	1.75	1.05	0.35	1.05	1.40	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	192.51	8.76	0.60	0.60	0.91	0.60	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	186.15	12.61	1.22	0.37	0.24	0.37	1.35	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	223.42	13.68	1.02	0.44	0.29	0.44	0.15	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	198.96	15.82	3.04	0.61	0.00	0.61	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	178.73	15.07	0.90	0.30	0.30	0.60	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	209.22	14.48	2.26	0.45	1.13	2.26	0.90	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	203.99	11.98	0.00	0.30	0.30	1.20	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	137.08	10.63	1.06	0.35	0.47	0.71	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	160.51	10.89	1.07	1.07	0.85	0.64	0.64	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	138.83	13.22	1.20	1.20	0.00	1.80	0.60	0.60
Schwann Cells, donor1	11498-119F4	77.11	8.28	0.56	0.38	0.75	0.19	0.19	0.00
Schwann Cells, donor2	11578-120F3	183.73	23.82	3.40	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	237.70	18.62	2.19	1.31	1.10	2.63	1.10	0.22
Sebocyte, donor1	11220-116B5	243.76	51.49	0.55	1.10	1.10	0.00	0.00	0.55
Sebocyte, donor2	11301-117B5	149.81	29.41	1.38	2.30	0.00	1.38	0.46	0.00
Sebocyte, donor3	11378-118B1	132.32	30.30	0.41	1.86	0.82	1.03	0.00	0.21
Sertoli Cells, donor1	11255-116F4	175.60	44.73	1.66	0.00	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	110.15	31.07	11.30	0.00	0.00	2.82	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	116.04	18.21	0.44	0.79	0.09	0.26	0.18	0.26
Skeletal Muscle Cells, donor2	11358-117H8	47.71	5.06	0.72	0.00	0.00	0.00	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	192.29	24.25	1.67	0.00	0.84	0.00	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	197.47	27.33	1.10	0.63	1.41	1.41	0.31	0.79
Skeletal Muscle Cells, donor5	11455-119A6	168.27	24.82	1.04	0.45	0.45	1.34	0.59	0.30
Skeletal Muscle Cells, donor6	11459-119B1	201.00	26.47	1.85	0.46	1.39	1.39	0.46	1.08
Skeletal Muscle Satellite Cells, donor1	11240-116D7	223.41	52.17	1.26	0.76	0.25	0.76	0.38	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	213.60	38.95	1.00	0.29	0.43	1.57	1.00	0.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	293.46	33.83	1.88	1.09	1.98	1.29	2.18	0.69
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	118.71	14.41	0.42	0.42	0.34	0.17	0.25	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	165.02	20.27	0.72	1.45	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	179.43	26.69	2.61	0.28	0.69	1.24	1.24	0.00
Skin - palm, donor1	10286-104F7	112.82	37.61	0.00	5.37	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	112.30	14.56	1.01	0.58	0.14	0.86	0.72	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	103.05	6.54	0.82	0.00	0.82	0.82	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	124.63	13.50	1.04	0.52	0.26	0.78	0.65	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	164.31	48.24	1.81	0.97	1.53	1.11	1.11	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	143.19	18.43	1.41	0.70	0.84	0.84	1.55	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	159.85	18.82	0.21	1.06	0.85	0.00	0.21	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	155.90	33.58	1.05	1.42	0.75	0.37	0.60	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	163.55	46.29	3.39	1.23	0.93	2.47	0.93	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	84.04	17.56	0.44	0.67	0.22	0.44	0.67	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	185.75	32.33	0.59	1.18	0.00	0.59	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	129.72	19.01	0.66	0.00	0.00	0.22	0.44	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	144.52	30.32	0.79	0.00	0.79	0.00	0.79	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	199.32	40.17	0.77	0.00	0.00	0.77	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	93.07	30.02	0.00	1.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	163.02	44.05	0.67	0.80	0.67	0.40	0.27	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	172.23	42.78	2.22	1.99	0.00	1.55	0.89	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	170.79	41.48	0.38	1.54	0.90	0.51	0.64	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	114.93	22.79	0.65	0.00	1.95	0.00	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	139.69	18.01	0.30	0.59	0.89	0.59	0.30	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	122.86	24.20	1.00	1.00	0.43	0.14	0.43	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	71.09	8.46	0.49	0.00	0.49	0.00	0.33	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	123.90	22.53	2.13	0.00	0.61	0.61	0.61	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	229.83	38.39	1.01	1.26	1.52	0.76	0.51	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	397.85	0.00	0.00	0.00	0.00	6.12	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	152.11	32.90	1.43	0.95	0.48	1.43	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	149.83	26.25	0.74	0.59	0.00	1.03	0.00	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	190.70	22.82	1.94	0.65	0.65	1.29	0.43	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	204.77	28.97	1.57	0.73	0.31	1.26	1.26	0.63
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	152.05	32.95	0.15	0.31	1.39	0.31	0.15	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	83.00	24.79	1.08	0.00	1.08	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	137.17	24.21	0.30	0.30	0.60	1.20	0.60	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	97.30	4.10	0.34	0.68	0.34	0.00	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	176.22	31.80	0.86	0.47	0.16	0.47	0.63	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	187.80	61.99	1.31	2.21	1.81	2.11	0.81	0.40
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	169.53	37.77	2.05	0.91	0.46	1.37	0.46	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	86.35	16.30	0.60	0.60	0.00	2.42	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	318.71	35.50	1.59	1.32	0.79	0.79	0.00	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	121.97	18.24	0.13	0.53	0.13	0.27	0.00	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	142.25	27.30	1.63	0.88	0.75	1.13	1.38	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	76.86	25.37	0.76	1.27	0.00	1.01	0.76	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	289.18	59.10	1.51	1.21	0.30	0.90	0.60	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	170.29	30.01	0.00	1.50	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	230.01	10.34	7.75	0.00	0.00	5.17	2.58	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	250.21	45.58	0.47	0.00	1.86	0.47	0.93	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	130.26	39.38	3.03	0.50	0.50	0.50	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	105.30	30.40	0.31	2.82	0.94	0.63	0.31	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	87.02	15.04	0.00	0.29	0.00	0.88	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	393.87	48.23	0.58	1.25	1.17	0.50	0.25	0.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	188.73	36.44	0.47	0.47	0.00	0.93	0.93	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	156.58	40.30	0.86	0.86	1.15	0.58	0.14	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	175.15	30.08	1.27	1.02	0.51	0.76	0.76	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	116.39	17.11	1.13	0.38	0.19	0.94	0.56	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	259.51	29.91	0.98	0.70	0.56	0.28	1.26	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	125.26	16.34	0.25	0.59	0.34	0.34	0.00	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	16.67	0.95	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	164.41	43.06	0.49	0.98	0.73	0.00	0.24	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	124.39	24.30	1.33	1.99	0.88	0.66	0.22	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	195.74	33.35	2.34	1.17	0.88	1.76	0.59	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	112.34	11.47	1.17	0.58	0.00	0.39	0.78	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	87.01	21.16	0.79	0.79	0.79	1.06	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	79.22	24.92	2.23	0.37	0.37	1.12	1.12	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	154.51	25.87	2.52	0.36	1.08	1.44	1.44	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	115.26	28.67	2.27	0.28	0.28	0.28	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	222.93	17.33	4.73	0.79	0.00	1.58	1.97	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	113.26	22.86	1.27	0.25	0.51	0.25	1.02	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	85.45	23.56	2.40	0.00	0.40	0.40	0.80	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	97.81	14.21	1.25	0.42	0.84	0.42	0.84	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	106.80	16.96	0.00	1.38	0.00	0.00	1.83	0.00
Synoviocyte, donor1	11291-117A4	156.87	29.46	1.01	1.01	0.17	0.17	0.84	0.34
Synoviocyte, donor2	11368-117I9	165.45	48.44	1.34	2.68	0.17	1.51	1.51	0.00
Synoviocyte, donor3	11440-118H9	120.19	27.70	2.01	0.89	0.00	2.01	0.45	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	146.51	9.65	0.36	0.36	0.71	0.36	0.00	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	45.59	7.93	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	100.49	8.34	0.23	0.23	0.23	0.23	0.46	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	104.59	23.73	0.57	0.43	0.07	0.14	0.22	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	126.02	23.19	0.00	0.77	0.77	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	76.74	10.88	0.57	0.00	0.00	0.57	1.15	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	111.71	15.75	0.37	0.86	0.12	0.37	0.12	0.12
Urethra, donor2	10319-105A4	79.13	8.99	0.00	0.00	1.80	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	88.47	11.16	0.53	0.00	1.33	0.00	0.00	0.27
Urothelial Cells, donor2	11600-120H7	65.69	12.82	0.40	0.00	0.80	1.20	0.80	0.00
Urothelial Cells, donor3	11681-122H7	63.95	8.71	0.46	0.92	0.00	0.23	0.92	0.23
Urothelial cells, donor0	11216-116B1	150.23	23.85	0.89	0.45	0.45	0.00	0.00	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	62.28	12.46	0.00	1.78	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	67.19	12.87	1.43	1.43	1.43	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	63.66	15.74	0.68	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	65.08	15.15	0.00	0.34	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	72.05	15.11	0.00	0.58	0.00	0.58	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	56.23	12.49	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	65.16	17.44	0.00	0.92	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	73.94	18.26	0.91	0.00	0.00	1.83	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	202.44	16.16	1.73	0.37	1.23	0.86	1.36	0.37
Wilms' tumor cell line:HFWT	10597-108E3	123.21	16.72	0.00	0.00	0.88	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	222.62	12.85	0.56	1.96	0.84	0.28	1.40	0.00
achilles tendon, donor2	10292-104G4	103.33	6.20	0.00	0.00	0.00	0.00	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	214.93	16.57	1.53	1.02	1.53	0.76	2.04	1.53
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	325.04	8.36	0.70	0.46	0.46	0.00	0.46	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	361.58	16.86	1.54	0.47	0.36	0.36	0.47	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	385.86	30.20	1.09	1.09	0.82	0.82	3.27	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	236.67	14.05	2.25	0.84	1.41	0.56	2.53	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	284.87	9.31	0.63	1.90	0.63	0.63	0.85	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	183.47	15.79	0.00	1.36	0.54	0.00	0.00	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	200.93	9.25	1.76	0.44	0.44	0.44	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	136.80	8.98	0.41	1.63	0.41	0.82	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	201.92	16.70	0.78	1.94	0.78	0.00	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	175.17	22.08	1.66	0.74	0.92	0.18	0.00	1.10
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	175.52	23.40	0.00	0.00	3.90	0.00	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	309.30	11.39	1.63	0.46	0.23	1.16	1.16	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	235.60	18.12	2.33	0.00	0.00	1.04	1.29	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	234.09	20.16	1.75	0.88	1.46	0.29	1.46	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	134.78	5.11	0.46	0.46	0.00	0.46	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	225.78	13.16	0.82	2.06	0.00	1.65	1.23	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	81.96	4.91	1.53	2.15	0.61	0.31	0.00	0.92
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	152.76	14.08	0.00	0.43	0.43	0.43	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	148.92	14.86	0.00	0.30	0.30	0.30	0.00	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	187.51	13.96	0.00	0.24	0.00	0.00	0.24	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	269.29	32.74	2.00	0.67	1.11	0.45	0.89	0.67
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	146.43	11.01	0.33	0.33	0.67	0.00	0.67	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	226.70	16.72	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	222.61	19.59	1.13	0.38	0.38	1.51	1.13	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	234.20	21.81	1.74	3.05	1.74	1.31	0.44	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	166.83	13.12	0.00	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	131.88	19.78	0.71	1.65	0.00	0.47	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	132.63	17.37	0.93	0.31	0.00	0.62	0.78	0.16
adipose, donor1	10184-103D4	237.50	68.02	5.86	0.59	0.00	9.97	4.10	0.00
adipose, donor2	10185-103D5	94.08	16.22	1.62	0.00	1.22	0.00	1.62	0.41
adipose, donor3	10186-103D6	166.91	24.51	2.45	1.09	0.54	1.09	2.18	0.27
adipose, donor4	10187-103D7	290.36	30.34	2.60	0.87	5.20	6.07	1.73	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	226.79	19.41	0.79	1.89	0.63	0.95	0.47	0.16
adrenal gland, adult, pool1	10081-102A9	47.29	3.64	0.00	3.64	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	358.46	43.22	1.47	2.67	0.13	0.67	0.53	0.67
alveolar cell carcinoma cell line:SW 1573	10708-109H6	545.60	37.52	1.79	1.79	3.93	1.43	2.14	0.00
amniotic membrane cells, donor1	12235-129G3	458.60	121.95	2.78	5.80	2.78	1.16	2.32	0.70
amniotic membrane cells, donor2	12236-129G4	221.12	16.57	1.01	1.35	0.00	0.68	1.69	0.00
amniotic membrane cells, donor3	12237-129G5	275.45	92.50	1.77	4.42	2.95	1.18	3.24	0.00
amygdala - adult, donor10196	10167-103B5	272.73	16.60	5.93	2.37	0.00	0.00	1.19	0.00
amygdala, adult, donor10252	10151-102I7	268.26	25.14	2.03	2.64	1.22	0.41	0.81	0.20
amygdala, newborn, donor10223	10360-105E9	170.42	21.30	1.61	0.65	4.20	0.97	0.65	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	106.07	11.33	0.25	0.51	0.25	0.00	0.13	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	275.56	19.41	1.76	3.31	1.99	1.10	0.88	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	275.58	27.73	1.00	0.00	0.33	0.67	1.34	0.33
aorta, adult, pool1	10052-101G7	111.80	8.63	0.59	0.59	0.00	1.18	0.59	0.00
appendix, adult	10189-103D9	145.93	16.69	0.39	0.39	0.39	0.39	0.00	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	215.30	17.54	1.03	0.69	1.38	0.00	1.38	1.03
artery, adult	10190-103E1	76.09	10.87	2.72	0.00	0.00	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	398.24	59.83	1.30	1.30	0.72	0.43	0.72	0.00
b cell line:RPMI1788	10427-106D4	109.44	18.14	0.00	0.30	0.00	0.15	0.00	0.89
basal cell carcinoma cell line:TE 354.T	10702-109G9	165.08	45.78	1.39	1.66	0.28	1.39	1.11	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	201.64	12.21	0.60	0.60	0.30	0.50	0.20	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	106.29	9.21	0.67	0.67	0.84	0.00	0.33	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	86.68	5.03	0.00	0.56	0.00	0.00	0.56	0.00
bladder, adult, pool1	10011-101C2	176.87	12.06	1.30	0.65	0.22	0.87	0.33	0.00
blood, adult, pool1	10053-101G8	93.01	11.07	0.00	0.00	0.00	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	208.95	28.26	0.00	1.71	0.00	0.86	0.00	0.00
bone marrow, adult	10192-103E3	191.65	18.90	4.72	0.00	0.00	2.02	4.05	0.67
brain, adult, donor1	10084-102B3	173.24	19.48	2.05	2.05	1.03	1.03	1.03	0.00
brain, adult, pool1	10012-101C3	285.86	30.73	1.78	2.12	0.45	0.67	1.22	0.22
brain, fetal, pool1	10085-102B4	419.41	34.73	2.67	0.00	0.00	2.67	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	173.77	14.54	1.65	0.66	0.66	0.99	0.66	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	254.14	41.69	0.87	2.12	0.62	0.12	0.37	0.50
breast, adult, donor1	10080-102A8	82.71	6.94	0.00	0.00	0.00	0.00	1.26	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	133.90	23.25	1.40	1.02	0.89	0.51	0.76	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	276.75	25.05	1.86	3.09	0.31	0.93	0.93	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	280.18	17.73	2.99	0.46	0.46	2.76	2.30	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	104.82	16.22	0.97	1.94	0.48	0.24	0.24	0.73
carcinoid cell line:NCI-H1770	10703-109H1	284.92	26.80	3.76	0.94	0.00	0.94	0.94	0.00
carcinoid cell line:NCI-H727	10735-110B6	281.87	24.06	1.20	1.20	0.98	0.33	0.00	0.44
carcinoid cell line:SK-PN-DW	10719-109I8	153.06	15.21	0.95	0.32	0.00	0.32	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	276.03	17.04	3.99	0.27	1.06	1.33	0.53	0.00
caudate nucleus - adult, donor10196	10177-103C6	218.75	17.27	4.61	2.30	1.15	0.00	2.30	1.15
caudate nucleus, adult, donor10252	10164-103B2	199.45	18.57	1.67	1.67	0.50	1.51	1.00	0.00
caudate nucleus, adult, donor10258	10379-105H1	139.84	21.40	1.53	0.76	0.76	0.00	1.53	0.76
caudate nucleus, newborn, donor10223	10354-105E3	158.21	21.61	3.30	0.37	1.10	1.10	0.37	0.73
cerebellum - adult, donor10196	10173-103C2	396.20	43.70	2.91	2.91	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	305.32	39.50	1.92	4.27	0.85	1.49	0.85	0.43
cerebellum, adult, pool1	10083-102B2	206.97	42.08	5.17	2.07	2.07	2.41	1.38	0.00
cerebellum, newborn, donor10223	10357-105E6	184.32	24.91	2.49	0.00	1.66	0.83	0.83	0.83
cerebral meninges, adult	10188-103D8	267.27	27.99	0.25	3.78	0.25	0.25	0.76	0.00
cerebrospinal fluid, donor2	10294-104G6	59.93	3.65	0.00	3.65	0.00	1.46	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	228.18	11.65	0.43	1.58	0.72	0.29	0.14	0.00
cervical cancer cell line:ME-180	10553-107I4	249.90	32.65	0.33	1.49	0.83	0.99	0.33	0.17
cervix, adult, pool1	10013-101C4	207.15	23.10	1.26	0.31	0.10	0.73	0.10	0.00
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	165.95	9.61	0.70	0.28	0.14	0.14	0.14	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	135.85	18.29	0.00	1.31	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	205.93	31.94	0.87	0.75	1.24	1.12	0.99	0.37
choriocarcinoma cell line:SCH	10785-110H2	214.39	12.07	1.11	0.37	0.49	0.74	0.12	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	170.06	16.84	1.19	0.95	1.19	0.00	0.24	0.71
chorionic membrane cells, donor1	12238-129G6	403.16	74.36	1.99	0.85	1.99	2.28	0.85	0.00
chorionic membrane cells, donor2	12239-129G7	169.83	28.34	0.99	0.40	0.50	0.40	0.99	0.20
chorionic membrane cells, donor3	12240-129G8	302.22	53.30	10.44	0.55	1.65	4.95	4.40	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	348.38	34.33	10.10	1.01	1.01	5.05	2.02	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	145.99	14.22	0.77	0.96	0.58	0.77	0.77	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	149.31	11.19	1.48	0.42	0.42	0.21	0.42	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	135.85	17.72	0.51	1.03	1.03	0.26	0.51	2.05
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	143.92	14.27	0.97	0.24	1.69	0.24	0.48	0.73
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	154.95	13.85	1.22	0.61	1.63	0.41	0.00	1.22
chronic myelogenous leukemia cell line:K562	10454-106G4	211.71	14.43	1.18	1.47	0.88	0.59	0.00	1.47
chronic myelogenous leukemia cell line:KU812	10409-106B4	217.36	14.07	0.26	0.78	0.00	0.26	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	122.75	8.46	1.37	0.69	0.00	0.91	1.37	0.00
clear cell carcinoma cell line:TEN	10636-108I6	77.73	3.82	0.87	0.52	0.52	0.17	0.00	0.00
colon carcinoma cell line:CACO-2	10513-107D9	256.99	31.30	1.10	0.73	1.46	0.37	0.18	0.55
colon carcinoma cell line:COLO-320	10420-106C6	389.96	37.25	2.66	0.00	1.90	1.14	0.76	0.38
colon, adult, donor1	10082-102B1	98.77	8.33	3.57	0.00	0.00	0.00	1.19	0.00
colon, adult, pool1	10014-101C5	124.91	21.15	0.59	1.88	0.24	0.35	0.00	0.00
colon, fetal, donor1	10070-101I7	81.57	21.01	0.62	4.33	0.00	0.62	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	435.43	4.58	0.00	4.58	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	300.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	318.27	20.40	1.70	0.85	1.27	1.27	0.42	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	355.14	20.83	0.91	0.91	2.72	0.60	1.21	0.60
cord blood derived cell line:COBL-a untreated	10449-106F8	450.11	23.27	1.27	1.27	2.40	0.56	1.27	0.56
corpus callosum, adult, pool1	10042-101F6	459.05	32.06	1.11	4.20	2.10	0.88	0.66	0.44
cruciate ligament, donor2	10295-104G7	116.71	12.16	1.62	0.81	0.00	0.81	1.62	0.00
diaphragm, fetal, donor1	10069-101I6	75.44	9.63	1.61	0.00	0.00	0.00	0.00	0.00
diencephalon, adult	10193-103E4	299.51	30.00	3.84	2.88	1.44	0.96	1.44	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	206.42	30.54	3.21	1.15	0.46	2.07	2.98	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	196.69	15.39	1.03	1.03	0.00	0.51	0.26	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	201.97	39.72	2.41	0.00	2.17	0.48	1.20	0.96
ductus deferens, adult	10196-103E7	103.65	10.96	1.00	1.00	0.00	0.00	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	90.73	12.96	4.32	1.44	0.00	1.44	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	184.65	14.71	2.21	0.00	0.00	0.74	2.21	0.00
dura mater, adult, donor1	10041-101F5	143.37	25.19	0.58	0.58	0.08	0.58	0.33	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	120.59	14.43	0.00	0.22	3.11	0.22	0.22	0.89
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	213.94	21.35	1.58	0.43	2.15	0.29	1.29	0.72
embryonic pancreas cell line:1B2C6	10604-108F1	255.28	17.27	0.62	0.62	1.23	0.00	0.62	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	261.84	26.64	3.33	0.30	1.51	2.12	1.21	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	275.10	21.30	0.31	0.93	0.93	0.31	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	306.04	23.64	0.00	1.31	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	126.70	13.74	0.67	1.34	2.35	1.01	0.67	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	226.54	15.59	1.63	1.27	0.36	0.54	1.27	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	169.18	15.92	4.34	0.32	1.77	1.29	1.13	0.00
epidermoid carcinoma cell line:A431	10426-106D3	356.60	37.79	1.67	1.22	0.78	0.11	0.22	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	317.75	18.37	0.99	1.10	0.99	0.33	0.44	0.11
epididymis, adult	10197-103E8	160.12	16.12	0.63	0.21	0.42	0.84	0.63	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	225.31	13.48	1.60	1.24	0.53	0.71	1.77	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	138.42	21.63	0.79	0.00	1.18	0.39	0.39	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	275.34	20.18	4.19	2.10	1.70	1.18	0.92	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	255.50	17.52	1.28	1.57	0.89	0.89	0.98	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	293.41	22.63	2.58	1.23	2.13	1.12	0.90	0.11
esophagus, adult, pool1	10015-101C6	166.91	51.60	0.96	0.85	0.96	0.64	0.64	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	157.55	5.39	0.25	0.13	0.13	0.13	0.13	0.25
eye - muscle inferior rectus, donor1	10272-104E2	57.95	4.83	0.00	0.00	0.00	2.41	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	54.71	4.21	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	68.46	0.00	0.00	0.00	0.00	1.49	0.00	0.00
eye - muscle superior, donor2	10297-104G9	68.79	0.00	0.00	0.00	0.00	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	122.42	1.46	0.00	4.37	0.00	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	205.17	19.07	2.54	1.27	0.51	1.53	1.53	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	149.51	16.54	0.90	0.77	0.13	0.64	1.03	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	276.83	26.83	0.71	0.71	1.19	0.24	0.95	0.24
frontal lobe, adult, pool1	10040-101F4	264.30	24.11	0.94	3.38	0.47	0.38	0.28	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	332.68	15.91	2.70	1.80	0.60	0.60	0.60	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	212.32	12.98	0.55	0.46	0.18	0.09	0.18	0.00
gall bladder, adult	10198-103E9	130.37	14.49	0.72	0.24	0.48	0.24	0.00	0.00
gamma delta positive T cells, donor1	11937-126A2	222.79	27.38	0.54	1.07	0.00	0.54	1.07	0.00
gamma delta positive T cells, donor2	11938-126A3	170.31	20.54	0.75	0.37	0.00	0.75	0.37	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	219.67	11.83	4.65	0.63	0.63	2.96	1.69	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	50.09	9.86	0.00	0.58	0.19	0.19	0.19	0.00
gastric cancer cell line:AZ521	10549-107H9	216.58	23.45	0.49	0.16	1.15	0.82	0.49	0.16
gastric cancer cell line:GSS	10560-108A2	111.66	6.41	0.92	0.00	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	191.45	9.14	0.91	0.23	1.14	1.37	1.37	0.00
giant cell carcinoma cell line:LU65	10487-107B1	134.93	9.64	0.80	0.57	0.23	0.11	0.34	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	249.41	50.67	0.98	0.28	0.70	0.28	0.14	0.56
glassy cell carcinoma cell line:HOKUG	10688-109F4	201.78	27.93	1.25	1.50	1.00	0.50	1.25	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	361.20	49.72	2.01	0.32	1.90	0.74	1.27	0.53
glioblastoma cell line:A172, tech_rep2	10444-106F3	341.55	41.57	0.70	0.42	1.83	0.70	2.11	1.12
glioblastoma cell line:T98G	10485-107A8	222.62	16.34	0.77	0.00	0.44	0.33	0.55	0.22
glioma cell line:GI-1	10413-106B8	316.60	23.72	1.76	1.17	2.05	2.05	0.59	0.59
globus pallidus - adult, donor10196	10175-103C4	283.55	26.97	2.92	1.46	1.46	0.73	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	350.03	25.87	2.20	3.91	1.22	1.95	1.95	0.24
globus pallidus, adult, donor10258	10367-105F7	230.03	19.17	2.74	1.37	0.00	2.74	2.74	0.00
globus pallidus, newborn, donor10223	10364-105F4	148.15	17.59	1.07	3.20	0.00	0.53	1.60	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	494.32	17.13	0.00	4.89	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	142.07	32.79	0.00	0.00	0.00	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	240.42	15.68	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	204.48	12.48	1.92	0.96	0.00	2.88	0.64	0.00
hIPS +CCl2, biol_rep1	14383-156B9	207.98	26.63	1.38	0.00	1.84	0.92	0.00	0.46
hIPS +CCl2, biol_rep2	14384-156C1	199.37	21.49	3.20	0.00	0.46	0.91	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	182.92	22.54	1.29	0.64	1.29	0.64	0.00	0.00
hIPS, biol_rep1	14380-156B6	218.47	37.37	4.31	0.00	2.87	1.44	0.00	0.00
hIPS, biol_rep2	14381-156B7	235.25	29.49	0.69	0.00	0.69	0.69	0.00	0.69
hIPS, biol_rep3	14382-156B8	186.49	8.83	1.10	0.00	3.31	0.00	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	212.92	19.54	0.86	0.57	1.15	1.15	1.15	0.00
heart - mitral valve, adult	10205-103F7	123.77	9.57	0.90	0.90	0.00	1.49	0.30	0.00
heart - pulmonic valve, adult	10206-103F8	126.82	6.54	0.52	0.52	0.00	0.26	0.26	0.00
heart - tricuspid valve, adult	10207-103F9	114.07	9.99	0.83	0.00	0.00	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	130.39	6.53	1.22	0.61	0.00	0.61	0.82	0.00
heart, adult, diseased, donor1	10051-101G6	126.05	6.39	2.98	0.43	0.00	2.55	0.43	0.00
heart, adult, pool1	10016-101C7	151.56	11.27	0.23	0.00	0.23	0.23	0.46	0.00
heart, fetal, pool1	10046-101G1	239.66	10.06	0.82	0.62	0.10	0.21	0.21	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	88.24	17.28	0.31	1.85	0.00	0.62	1.23	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	126.05	11.89	0.00	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	394.14	24.75	2.21	1.44	6.30	1.22	1.33	1.44
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	416.68	27.43	4.37	1.34	5.70	1.82	1.58	3.88
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	418.16	31.63	2.73	1.11	6.67	0.71	1.52	2.02
hepatoma cell line:Li-7	10484-107A7	134.24	8.56	0.44	0.11	0.56	0.33	0.11	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	181.81	26.53	0.40	0.60	1.01	0.50	0.60	0.40
hippocampus - adult, donor10196	10169-103B7	203.46	25.55	1.89	3.79	1.89	0.00	0.00	0.95
hippocampus, adult, donor10252	10153-102I9	246.96	22.86	1.63	2.04	0.00	0.82	1.22	0.00
hippocampus, adult, donor10258	10374-105G5	179.26	9.46	2.49	1.99	1.00	0.50	1.00	0.00
hippocampus, newborn, donor10223	10363-105F3	152.27	18.68	1.41	2.82	0.35	1.76	1.41	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	299.68	65.31	15.26	0.00	3.66	5.49	4.27	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	222.27	46.54	2.55	0.20	4.52	2.36	1.77	0.98
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	242.98	57.89	3.30	0.51	4.06	1.78	1.52	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	154.50	37.22	3.38	0.00	0.00	2.26	2.26	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	195.72	45.19	23.24	0.00	1.55	11.10	11.36	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	206.89	59.22	4.18	0.00	1.90	1.52	1.14	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	209.33	42.04	3.50	0.29	2.04	2.63	1.46	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	200.35	40.29	2.59	0.65	1.94	2.59	1.72	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	209.37	39.62	3.75	1.67	3.34	1.25	1.25	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	376.97	51.15	2.84	1.66	2.60	1.42	0.47	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	276.75	36.96	4.18	1.13	2.09	2.89	1.29	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	354.16	35.01	0.67	0.67	2.02	0.67	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	179.64	63.22	3.13	0.63	7.04	2.97	0.63	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	187.67	56.01	17.20	0.00	3.93	7.86	5.40	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	171.93	62.84	6.11	0.00	3.49	3.49	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	186.71	52.12	2.86	0.00	1.53	2.48	1.15	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	154.37	39.25	1.31	0.00	1.31	0.44	0.00	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	131.94	41.48	8.00	0.50	0.00	6.00	4.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	125.47	27.32	2.45	0.19	0.57	1.32	0.94	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	130.50	25.92	3.18	0.00	1.36	0.00	1.36	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	126.23	26.31	2.19	0.00	0.00	1.25	0.63	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	235.15	25.48	3.76	0.49	2.61	2.78	1.63	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	231.38	21.77	0.87	0.87	1.74	3.19	0.87	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	187.13	20.33	4.18	0.90	0.90	2.99	2.09	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	204.70	57.27	4.25	0.37	4.99	2.03	1.48	1.48
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	197.13	53.35	0.86	0.57	3.71	0.57	0.00	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	278.06	77.17	2.86	0.82	6.94	3.67	2.45	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	226.74	43.31	15.49	0.35	1.41	7.04	5.63	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	158.69	40.86	1.90	0.00	0.95	1.90	1.58	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	194.28	45.39	4.54	0.30	1.51	2.72	0.91	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	180.99	24.30	0.00	0.00	0.52	0.52	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	172.02	22.58	3.98	0.66	1.33	0.00	1.33	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	209.07	26.94	0.77	0.00	1.03	0.00	0.51	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	246.19	25.56	6.14	0.51	2.81	5.37	2.05	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	233.22	21.96	3.03	1.51	1.51	1.51	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	228.52	26.21	2.69	0.67	0.67	1.34	1.01	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	189.10	51.20	1.93	0.24	5.07	1.45	1.21	1.69
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	205.00	65.07	3.57	0.45	4.01	4.46	0.89	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	186.34	58.05	2.93	0.00	3.90	0.98	2.44	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	179.09	46.15	2.44	0.00	0.61	2.44	1.53	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	712.46	162.66	55.31	3.25	0.00	26.03	22.77	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	228.68	63.87	5.30	0.00	0.99	2.98	1.32	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	194.84	33.39	6.02	0.00	0.55	1.09	2.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	187.09	35.46	2.90	0.72	0.72	2.53	0.36	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	177.58	39.15	3.56	0.36	0.71	1.07	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	204.07	26.25	7.16	0.00	2.39	1.19	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	346.55	44.69	2.84	0.81	1.63	2.17	0.68	0.54
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	221.17	32.06	1.89	0.00	1.62	1.62	0.81	0.81
immature langerhans cells, donor1	11904-125F5	127.85	14.04	2.42	0.48	0.00	0.24	0.00	0.00
immature langerhans cells, donor2	11905-125F6	113.27	11.88	0.79	2.38	0.00	0.00	0.79	0.00
insula, adult, pool1	10039-101F3	262.70	26.59	0.76	3.03	0.47	0.47	0.19	0.38
keratoacanthoma cell line:HKA-1	10791-110H8	116.08	23.74	0.65	0.33	0.33	0.33	1.63	0.00
kidney, adult, pool1	10017-101C8	158.30	16.42	0.60	0.20	0.20	0.20	0.60	0.10
kidney, fetal, pool1	10045-101F9	184.41	7.99	0.35	0.14	0.21	0.50	0.28	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	224.53	17.04	0.57	1.56	0.85	0.28	0.14	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	115.16	31.66	2.49	0.69	0.83	1.38	0.41	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	225.70	11.38	0.55	0.92	0.37	0.00	0.37	0.00
left atrium, adult, donor1	10079-102A7	50.67	8.17	1.63	0.00	0.00	0.00	0.54	0.00
left ventricle, adult, donor1	10078-102A6	79.89	5.56	0.51	0.00	0.00	0.51	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	331.34	40.49	1.37	1.09	0.27	1.37	0.55	0.00
leiomyoma cell line:10964C	10569-108B2	214.11	70.41	6.47	2.87	1.80	3.59	4.67	0.36
leiomyoma cell line:15242A	10570-108B3	166.31	53.80	3.26	1.63	1.09	2.17	1.09	1.09
leiomyoma cell line:15425	10571-108B4	259.81	58.52	9.71	0.97	1.94	3.64	6.80	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	171.43	44.45	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	166.24	6.27	3.14	0.00	0.00	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	121.60	10.27	0.35	1.30	0.12	0.24	0.12	0.12
liposarcoma cell line:KMLS-1	10782-110G8	185.58	59.67	0.62	2.19	0.62	0.47	0.94	0.16
liposarcoma cell line:SW 872	10726-110A6	189.83	9.75	0.49	0.97	0.24	0.37	1.10	0.12
liver, adult, pool1	10018-101C9	112.31	12.32	0.49	0.16	0.16	0.16	0.00	0.00
liver, fetal, pool1	10086-102B5	62.09	7.53	0.00	0.94	0.00	2.82	1.88	0.00
locus coeruleus - adult, donor10196	10182-103D2	208.97	23.77	2.04	1.60	1.31	0.44	1.17	0.15
locus coeruleus, adult, donor10252	10165-103B3	267.78	24.36	2.77	3.32	1.66	1.48	1.85	0.37
locus coeruleus, adult, donor10258	10375-105G6	172.10	19.47	3.67	2.82	0.28	1.41	2.54	0.00
locus coeruleus, newborn, donor10223	10362-105F2	164.88	14.72	2.10	0.42	1.68	0.42	1.26	0.00
lung adenocarcinoma cell line:A549	10499-107C4	197.07	19.24	0.14	1.25	0.00	0.14	0.00	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	186.14	17.24	0.00	0.69	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	218.95	19.51	1.05	0.79	0.13	0.92	0.13	0.26
lung, adult, pool1	10019-101D1	134.43	22.44	0.35	0.71	0.35	0.71	0.00	0.00
lung, fetal, donor1	10068-101I5	188.37	8.56	0.29	0.86	0.29	0.00	0.00	0.00
lung, right lower lobe, adult, donor1	10075-102A3	83.40	10.08	1.83	0.92	0.00	0.46	0.46	0.00
lymph node, adult, donor1	10077-102A5	73.84	13.25	1.89	0.47	0.47	1.42	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	78.25	11.62	0.66	1.53	0.00	0.22	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	114.25	15.70	0.45	0.15	0.15	0.45	0.30	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	225.97	16.14	0.00	3.40	0.85	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	122.99	19.98	0.00	5.33	0.00	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	97.95	18.26	0.62	3.53	0.00	0.62	0.21	0.42
mature adipocyte, donor3	12233-129G1	94.35	15.65	0.24	4.03	0.24	0.00	0.24	0.00
mature adipocyte, donor4	12234-129G2	126.34	17.37	0.00	3.95	0.26	0.53	0.26	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	170.83	21.92	0.71	0.48	1.67	0.48	0.00	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	209.81	18.05	3.38	3.38	0.00	1.13	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	218.66	21.52	1.84	2.76	1.29	0.55	1.10	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	143.91	9.53	4.13	0.64	0.95	0.64	2.54	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	270.82	19.62	6.82	0.85	0.43	4.69	3.41	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	253.13	21.77	15.86	1.69	1.18	6.24	7.26	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	255.94	22.07	2.12	1.91	0.21	0.21	1.70	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	119.43	9.63	7.71	1.93	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	373.19	43.06	0.00	0.00	0.00	0.00	28.71	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	214.64	17.23	1.79	0.72	1.08	0.72	1.08	0.00
medulla oblongata - adult, donor10196	10174-103C3	157.70	11.68	1.95	1.30	1.30	1.30	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	238.71	20.12	2.17	1.24	1.55	0.15	1.08	0.62
medulla oblongata, adult, pool1	10038-101F2	276.96	33.39	0.98	1.71	1.96	0.73	0.16	0.24
medulla oblongata, newborn, donor10223	10361-105F1	178.80	19.79	3.12	0.35	0.69	0.35	0.35	0.35
medulloblastoma cell line:D283 Med	10838-111E1	263.04	15.72	1.99	0.22	1.11	2.44	0.66	0.22
medulloblastoma cell line:ONS-76	10759-110E3	228.41	15.77	0.98	0.73	1.83	0.24	0.61	0.24
melanoma cell line:COLO 679	10514-107E1	117.01	17.25	0.14	1.15	0.00	0.00	0.14	0.14
melanoma cell line:G-361	10465-106H6	93.38	11.94	0.81	0.81	0.27	0.54	0.27	0.54
meningioma cell line:HKBMM	10691-109F7	174.57	20.44	4.52	0.72	0.54	2.17	1.45	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	400.05	44.94	2.64	0.00	3.52	7.05	1.76	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	413.46	43.81	2.59	2.07	2.07	1.56	2.07	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	245.03	53.55	2.61	2.61	0.15	1.38	1.23	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	110.52	25.45	1.45	0.73	0.36	0.73	0.36	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	176.82	32.30	2.90	1.66	0.00	2.48	1.66	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	143.14	37.93	0.70	1.26	0.42	0.70	0.84	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	137.30	32.16	1.73	0.77	0.00	0.96	0.19	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	153.39	42.34	2.08	0.69	0.69	0.00	0.00	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	136.28	40.16	1.20	0.86	0.00	0.51	0.51	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	165.51	33.81	2.19	0.81	0.69	0.46	0.92	0.35
mesenchymal precursor cell - cardiac, donor3	11754-123G8	260.10	32.76	2.25	1.86	0.27	1.33	1.06	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	231.86	40.38	0.68	1.62	0.81	1.49	1.22	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	206.28	38.98	1.99	0.85	0.57	1.99	1.14	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	96.83	21.08	0.99	1.32	0.66	0.33	0.99	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	191.92	31.41	1.66	0.69	0.42	0.97	0.55	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	253.09	49.92	0.70	1.05	0.70	0.35	1.05	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	187.63	51.04	1.84	1.63	0.20	0.82	1.63	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	120.42	18.33	0.72	0.72	0.36	0.36	0.36	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	142.24	28.35	1.14	0.93	0.31	0.83	0.72	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	159.37	35.11	1.37	0.68	0.68	0.68	0.91	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	351.17	43.21	4.20	1.26	1.68	4.20	1.68	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	133.15	23.46	1.05	0.75	0.30	0.60	0.90	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	176.37	28.89	1.66	1.49	0.88	1.40	0.61	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	123.33	21.35	0.74	0.37	0.74	0.37	0.74	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	133.06	28.62	1.43	0.57	1.43	0.57	1.72	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	402.91	34.94	6.32	1.26	0.42	3.79	5.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	171.25	37.45	0.91	1.37	0.00	0.46	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	169.33	25.58	2.05	1.28	0.00	0.26	0.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	207.31	32.20	1.05	1.31	0.52	1.05	0.79	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	180.23	29.88	1.85	0.92	0.62	0.92	1.23	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	172.04	32.71	1.65	0.71	0.00	1.65	0.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	180.74	28.77	2.37	0.68	0.00	2.71	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	196.09	30.26	0.79	0.00	0.39	1.57	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	172.38	27.34	3.24	0.46	0.00	0.46	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	96.61	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	204.49	31.15	1.73	1.73	0.58	1.15	1.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	205.70	34.58	0.45	1.34	0.89	0.45	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	193.72	31.25	1.68	0.72	0.72	0.72	0.72	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	209.00	35.20	5.13	1.47	2.20	1.47	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	181.93	29.20	2.01	0.67	0.00	1.34	0.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	180.13	33.16	1.64	1.64	0.00	1.23	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	186.86	36.51	1.29	0.43	0.43	2.15	1.29	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	142.19	30.08	0.00	2.73	0.00	0.00	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	165.28	51.65	0.00	0.00	0.00	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	168.56	30.53	1.95	0.65	0.00	0.97	0.32	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	164.41	24.73	0.00	0.00	0.00	2.91	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	143.93	23.46	1.60	2.67	0.53	0.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	147.20	21.26	1.64	2.45	0.00	2.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	150.43	33.04	0.78	0.78	0.78	1.55	1.17	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	170.00	16.79	2.10	6.30	0.00	2.10	4.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	126.17	32.78	0.00	1.99	0.00	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	138.25	9.53	0.00	0.00	0.00	0.00	9.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	144.68	35.58	1.78	1.78	0.59	1.19	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	198.61	37.77	0.00	0.00	0.00	2.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	162.31	27.05	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	157.71	25.97	1.27	1.27	0.63	0.63	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	96.23	21.04	1.38	2.07	0.00	0.69	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	118.21	32.24	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	123.75	43.91	11.98	0.00	0.00	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	72.32	0.00	0.00	0.00	0.00	0.00	6.89	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	71.31	16.30	0.81	0.81	0.00	0.81	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	92.95	21.45	0.79	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	82.53	14.15	1.77	0.59	0.00	0.59	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	72.00	11.84	0.31	0.31	0.00	0.31	1.25	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	74.85	16.04	1.34	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	80.42	16.56	1.18	0.00	0.00	0.00	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	112.99	15.41	2.57	0.00	0.00	0.00	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	111.52	23.41	0.69	2.07	0.69	2.07	0.69	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	87.09	21.77	0.49	1.48	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	72.90	17.94	2.24	0.00	0.00	0.00	2.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	73.15	13.99	1.91	0.00	0.00	0.00	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	72.94	17.33	0.40	1.21	0.00	0.81	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	89.40	32.71	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	76.02	15.20	0.00	1.27	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	54.62	12.14	0.00	1.21	0.61	0.61	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	36.15	4.52	0.00	0.00	4.52	0.00	0.00	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	52.72	12.36	0.82	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	75.40	17.86	0.40	2.18	0.20	0.40	0.60	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	75.93	14.93	0.97	1.30	0.00	0.00	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	110.01	22.41	0.00	1.02	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	138.49	13.15	0.00	0.00	0.77	0.00	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	269.32	33.31	0.00	0.71	0.71	0.00	0.24	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	173.99	12.51	1.16	1.16	0.23	0.23	0.70	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	273.51	21.37	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	184.33	15.82	5.45	0.41	0.62	2.57	3.08	0.10
mesothelioma cell line:Mero-25	10850-111F4	74.44	4.77	0.23	0.23	0.45	0.23	0.45	0.00
mesothelioma cell line:Mero-41	10851-111F5	226.87	26.40	0.98	0.98	0.98	1.71	0.98	0.00
mesothelioma cell line:Mero-48a	10852-111F6	327.27	27.46	3.54	1.55	0.44	0.89	0.66	0.22
mesothelioma cell line:Mero-82	10853-111F7	182.12	8.67	2.63	0.00	0.26	0.26	1.58	0.00
mesothelioma cell line:Mero-83	10854-111F8	304.35	24.17	2.72	1.19	0.68	0.85	1.70	0.34
mesothelioma cell line:Mero-84	10855-111F9	213.34	15.92	1.26	0.51	0.51	1.52	1.01	0.00
mesothelioma cell line:Mero-95	10856-111G1	174.54	15.53	1.66	0.62	0.21	0.21	0.62	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	634.76	47.87	3.15	1.49	2.48	0.99	2.48	0.50
mesothelioma cell line:NCI-H226	10846-111E9	198.19	15.20	1.63	0.36	0.54	0.72	1.45	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	234.37	30.58	0.68	0.68	0.34	0.68	2.22	0.34
mesothelioma cell line:NCI-H28	10845-111E8	217.57	25.70	1.78	0.25	1.02	1.02	3.31	1.27
mesothelioma cell line:No36	10857-111G2	115.15	8.81	0.00	0.00	0.00	0.65	1.30	0.98
mesothelioma cell line:ONE58	10858-111G3	139.00	15.72	0.54	0.00	0.27	0.81	1.08	0.00
migratory langerhans cells, donor1	11901-125F2	190.00	14.59	2.88	0.00	0.19	0.58	0.77	0.00
migratory langerhans cells, donor2	11902-125F3	126.15	11.48	0.61	0.24	0.24	0.12	0.12	0.12
migratory langerhans cells, donor3	11903-125F4	163.69	12.92	0.54	0.18	0.00	0.90	0.36	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	119.49	4.90	2.29	0.65	0.33	1.31	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	225.50	9.96	2.76	2.97	0.42	1.06	2.12	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	100.67	9.68	0.23	1.38	0.00	0.00	0.23	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	578.68	52.71	3.81	2.09	4.95	1.14	0.95	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	209.55	12.20	0.74	0.37	0.55	0.18	0.37	0.74
myeloma cell line:PCM6	10474-106I6	93.89	18.58	0.40	1.58	1.19	0.20	0.40	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	273.43	15.73	1.01	2.03	0.00	0.51	0.00	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	254.20	20.99	1.18	0.39	0.00	0.59	0.39	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	64.63	31.20	0.22	1.11	0.00	0.00	0.11	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	71.63	26.25	0.15	1.18	0.29	0.15	0.15	0.07
nasal epithelial cells, donor2	12227-129F4	200.92	35.33	0.00	0.00	0.55	0.00	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	244.09	46.24	0.00	0.69	8.05	0.46	0.92	1.15
neuroblastoma cell line:NB-1	10539-107G8	415.14	26.00	0.37	0.75	4.12	0.37	0.94	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	169.13	29.10	0.84	0.63	3.80	0.42	0.42	0.21
neuroblastoma cell line:NH-12	10555-107I6	441.28	50.50	1.12	0.19	10.06	1.30	0.93	1.68
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	159.18	13.76	0.71	0.71	0.24	1.42	0.47	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	148.09	9.34	1.58	0.00	0.32	1.11	0.48	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	102.04	7.25	0.20	0.60	1.01	0.00	0.20	0.60
neuroepithelioma cell line:SK-N-MC	10728-110A8	201.54	19.07	0.64	0.00	1.27	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	147.46	24.75	0.80	1.06	0.27	0.53	0.00	0.00
neutrophil PMN, donor1	12133-128D9	252.87	14.87	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	66.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	0.00	0.00	9.47	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	412.48	14.04	1.52	0.51	0.68	0.51	0.68	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	726.86	89.66	1.60	0.80	13.61	0.00	0.80	2.40
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	127.92	12.18	1.28	1.28	0.96	0.32	0.64	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	142.94	19.18	3.42	0.53	0.00	1.58	2.10	0.00
nucleus accumbens, adult, pool1	10037-101F1	255.35	26.43	0.66	1.78	0.94	0.09	0.37	0.28
occipital cortex - adult, donor10196	10172-103C1	230.76	8.24	6.18	0.00	0.00	0.00	4.12	0.00
occipital cortex, adult, donor10252	10163-103B1	261.12	22.54	2.15	2.95	0.54	0.54	0.00	0.00
occipital cortex, newborn, donor10223	10355-105E4	224.19	20.02	1.09	1.82	1.82	0.00	0.36	0.00
occipital lobe, adult, donor1	10076-102A4	218.32	23.88	1.31	6.82	1.05	2.36	0.79	0.26
occipital lobe, fetal, donor1	10073-102A1	568.99	39.48	2.57	4.29	1.29	2.15	3.00	0.43
occipital pole, adult, pool1	10036-101E9	241.81	26.81	0.55	2.44	0.39	0.24	0.32	0.24
olfactory region, adult	10195-103E6	214.55	23.12	2.29	1.53	1.34	1.15	1.15	0.19
optic nerve, donor1	10277-104E7	270.14	22.01	0.00	2.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	327.26	69.14	0.68	3.87	2.73	0.57	0.68	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	191.24	35.86	0.69	0.27	0.41	0.14	0.00	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	168.14	15.75	2.03	0.34	0.51	1.19	2.03	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	171.53	12.13	0.58	0.92	0.35	0.81	0.35	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	186.96	29.10	0.29	2.06	0.59	0.29	0.59	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	123.33	7.47	0.00	0.00	0.00	0.00	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	151.41	10.39	0.21	0.85	0.42	0.42	0.00	0.21
ovary, adult, pool1	10020-101D2	202.48	10.57	0.79	0.61	0.00	0.26	0.09	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	237.95	19.43	1.65	1.28	0.73	0.92	1.28	0.37
pancreas, adult, donor1	10049-101G4	129.81	95.00	6.58	2.82	3.76	0.94	2.82	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	112.65	8.67	0.00	0.84	0.56	0.56	0.28	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	167.63	10.90	2.90	0.17	0.00	1.70	1.19	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	178.17	10.27	0.50	0.66	0.33	0.17	0.00	0.17
paracentral gyrus, adult, pool1	10035-101E8	273.74	32.95	0.92	3.57	0.73	0.27	0.27	0.18
parietal cortex, adult, donor10258	10373-105G4	223.14	10.28	0.73	0.73	0.00	0.73	1.47	0.00
parietal lobe - adult, donor10196	10171-103B9	220.07	11.29	0.94	1.88	0.00	0.94	2.82	0.00
parietal lobe, adult, donor10252	10157-103A4	207.79	19.38	1.43	2.28	1.14	0.86	1.71	0.29
parietal lobe, adult, pool1	10034-101E7	260.04	29.17	1.06	3.26	0.62	0.44	0.26	0.26
parietal lobe, fetal, donor1	10072-101I9	453.88	31.03	4.85	0.97	1.94	0.97	6.79	0.97
parietal lobe, newborn, donor10223	10356-105E5	230.67	23.93	0.75	0.75	1.12	0.37	1.12	0.00
parotid gland, adult	10199-103F1	117.78	89.42	0.62	4.93	0.62	0.00	0.00	1.23
penis, adult	10200-103F2	143.41	13.43	4.30	1.07	0.00	0.00	1.61	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	80.88	16.18	0.37	0.00	0.00	0.37	0.74	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	88.87	4.66	0.87	0.44	0.29	0.15	0.00	0.00
pineal gland - adult, donor10196	10179-103C8	252.21	34.83	3.23	1.29	0.00	0.00	1.29	1.29
pineal gland, adult, donor10252	10160-103A7	267.68	36.12	1.78	0.00	0.00	0.00	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	158.02	26.96	3.14	0.00	0.63	0.00	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	222.60	22.26	1.01	3.04	1.01	0.00	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	300.20	40.65	0.00	0.00	1.04	0.00	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	156.63	21.28	0.00	0.85	0.85	0.85	0.85	0.00
placenta, adult, pool1	10021-101D3	107.93	13.87	0.11	0.43	0.54	0.22	0.32	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	151.89	12.85	1.06	0.00	0.53	1.06	0.53	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	264.12	17.43	1.56	0.78	0.31	0.31	0.16	0.00
pons, adult, pool1	10033-101E6	284.11	40.37	1.03	4.30	1.64	0.17	0.34	0.26
postcentral gyrus, adult, pool1	10032-101E5	274.43	28.94	1.31	3.66	1.05	0.78	0.78	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	217.51	8.37	0.00	6.27	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	126.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	58.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	229.42	22.87	1.46	1.60	0.44	0.44	1.75	0.73
prostate cancer cell line:PC-3	10439-106E7	309.82	24.87	1.09	1.09	0.36	0.91	0.36	0.73
prostate, adult, pool1	10022-101D4	164.61	13.33	0.73	0.45	0.00	0.36	0.18	0.09
putamen, adult, donor10196	10176-103C5	256.37	25.73	1.65	1.18	0.00	0.24	2.12	0.24
putamen, adult, donor10252	10152-102I8	203.92	27.45	1.96	0.00	0.00	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	103.82	18.58	3.28	1.09	0.00	1.09	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	189.91	21.26	1.69	1.93	0.48	0.24	0.97	0.48
putamen, newborn, donor10223	10365-105F5	169.42	13.49	0.00	0.00	0.75	0.75	3.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	114.05	11.35	0.29	0.87	0.29	0.00	0.29	0.00
rectum, fetal, donor1	10067-101I4	208.65	9.74	0.00	5.56	1.39	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	182.11	15.05	1.27	1.27	0.42	0.21	0.64	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	96.51	19.47	0.83	1.24	0.83	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	160.33	11.73	0.50	0.60	0.10	0.30	0.20	0.20
retinoblastoma cell line:Y79	10475-106I7	411.79	57.68	1.56	0.52	10.13	1.04	1.30	2.08
rhabdomyosarcoma cell line:KYM-1	10787-110H4	149.26	17.34	0.86	1.84	0.37	0.12	0.12	0.61
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	245.49	14.34	1.41	0.28	1.69	0.56	0.28	2.25
sacrococcigeal teratoma cell line:HTST	10695-109G2	207.65	25.01	0.00	0.76	0.00	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	128.84	53.74	2.10	1.46	0.32	2.10	0.81	0.00
salivary acinar cells, donor2	11772-123I8	149.25	53.56	3.03	1.24	0.41	0.83	1.38	0.28
salivary acinar cells, donor3	11773-123I9	116.52	46.34	1.32	1.99	0.00	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	76.07	44.61	0.57	4.58	1.72	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	79.93	18.13	0.51	0.08	0.00	0.25	0.17	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	74.06	13.17	0.47	0.12	0.24	0.35	0.12	0.12
seminal vesicle, adult	10201-103F3	99.99	15.34	0.00	0.00	0.53	1.59	2.65	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	287.38	15.06	3.16	1.94	0.49	0.97	1.70	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	181.18	6.79	1.01	0.25	0.25	0.25	0.25	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	255.90	23.08	2.01	0.00	0.00	2.01	2.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	175.96	15.98	1.07	0.27	1.48	0.27	0.81	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	279.41	27.41	0.55	1.11	0.22	0.22	0.22	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	186.18	25.29	0.39	2.45	1.42	0.26	0.26	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	34.05	1.42	0.00	0.00	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	66.33	8.16	0.48	0.12	0.12	0.12	0.24	0.12
skeletal muscle, fetal, donor1	10066-101I3	80.40	13.07	0.00	0.00	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	47.50	40.71	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	126.88	14.52	2.52	0.63	0.00	1.26	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	267.82	85.05	1.33	2.00	1.33	2.00	2.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	418.28	11.66	5.36	0.00	1.58	2.52	2.52	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	259.25	16.96	2.12	0.19	0.77	0.58	1.16	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	354.87	92.96	0.82	0.16	2.97	0.33	0.66	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	314.30	17.05	2.57	0.00	2.09	0.97	0.80	0.64
small cell lung carcinoma cell line:WA-hT	10562-108A4	402.28	13.08	0.44	3.05	2.18	0.87	0.87	0.44
small intestine, adult, pool1	10024-101D6	109.05	39.06	0.84	4.30	0.24	0.48	0.12	0.12
small intestine, fetal, donor1	10064-101I1	128.25	19.41	2.70	1.23	0.00	0.25	0.00	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	169.77	18.46	6.67	0.51	2.56	3.08	3.08	0.00
smooth muscle, adult, pool1	10048-101G3	140.60	10.34	0.52	0.26	0.52	1.03	0.78	0.00
somatostatinoma cell line:QGP-1	10781-110G7	191.90	34.57	1.34	1.88	2.14	0.54	0.54	0.80
spinal cord - adult, donor10196	10181-103D1	155.31	14.22	3.90	1.15	0.00	1.15	1.61	0.00
spinal cord, adult, donor10252	10159-103A6	169.14	14.19	0.00	0.79	0.79	0.79	0.39	0.00
spinal cord, adult, donor10258	10369-105F9	153.58	5.53	2.08	2.08	0.00	1.38	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	233.57	20.73	1.83	3.05	0.61	0.61	1.83	0.00
spinal cord, newborn, donor10223	10359-105E8	200.68	18.37	3.21	0.92	0.46	1.38	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	177.13	34.20	1.05	1.34	0.45	0.30	0.30	0.30
spleen, adult, pool1	10025-101D7	107.93	15.64	0.88	0.44	0.00	0.00	0.22	0.00
spleen, fetal, pool1	10044-101F8	129.51	9.38	0.32	0.56	0.16	0.00	0.16	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	139.12	24.43	0.72	0.41	0.52	0.00	0.31	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	160.26	16.90	1.14	0.19	0.19	0.19	0.38	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	152.01	12.93	4.54	1.05	0.00	0.70	2.80	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	152.85	15.64	0.78	1.95	0.78	0.39	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	157.69	10.36	0.79	2.14	1.58	0.00	0.23	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	286.35	55.49	1.69	1.27	1.27	2.54	0.42	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	217.46	13.12	0.00	0.00	0.00	1.27	0.00	0.42
stomach, fetal, donor1	10062-101H8	139.90	9.61	1.07	1.07	0.00	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	82.03	50.70	0.57	1.14	1.71	1.71	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	217.10	0.00	271.37	0.00	0.00	54.27	108.55	0.00
substantia nigra, adult, donor10252	10158-103A5	366.81	25.76	3.12	2.70	1.25	1.04	1.87	0.42
substantia nigra, adult, donor10258	10371-105G2	195.00	10.35	3.62	2.07	0.52	1.03	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	118.70	10.60	2.83	1.41	1.41	0.00	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	226.28	22.93	1.83	0.46	2.52	0.46	0.92	1.38
temporal lobe, adult, pool1	10031-101E4	272.11	25.43	1.36	1.78	0.85	0.76	0.59	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	455.14	30.63	2.14	6.41	0.00	4.99	2.14	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	457.56	26.81	3.96	0.44	2.64	3.96	3.96	0.88
tenocyte, donor1	11763-123H8	213.65	41.54	3.84	1.75	0.35	2.79	1.05	0.00
tenocyte, donor2	11765-123I1	167.48	25.18	3.82	1.53	0.00	1.14	1.91	0.38
tenocyte, donor3	11768-123I4	213.13	50.41	3.71	1.48	0.37	2.59	2.22	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	264.80	141.41	2.55	0.51	2.21	2.04	1.87	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	222.59	13.57	1.23	0.31	1.54	0.62	1.70	0.31
teratocarcinoma cell line:PA-1	10807-111A6	164.43	47.58	0.77	0.31	1.70	0.77	1.24	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	153.86	30.21	1.40	0.13	0.51	0.63	0.38	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	103.62	19.66	1.13	0.38	1.51	0.00	0.00	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	150.07	24.21	1.09	0.33	0.76	0.22	0.22	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	367.07	25.08	11.07	0.33	3.58	4.56	4.89	0.33
testis, adult, pool1	10026-101D8	256.41	25.66	1.29	0.43	0.97	1.07	0.75	0.97
testis, adult, pool2	10096-102C6	281.03	18.95	7.22	0.90	0.45	2.26	1.35	0.90
thalamus - adult, donor10196	10168-103B6	315.74	16.56	1.10	2.21	2.21	0.00	0.00	1.10
thalamus, adult, donor10252	10154-103A1	339.60	20.63	2.66	1.56	1.09	0.47	0.31	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	120.09	13.86	4.62	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	115.94	14.66	0.99	1.98	0.66	0.66	2.96	0.16
thalamus, newborn, donor10223	10366-105F6	140.95	16.68	3.45	0.58	1.15	1.15	0.58	0.00
throat, adult	10209-103G2	93.88	18.97	0.50	0.75	0.00	0.25	0.00	0.00
throat, fetal, donor1	10061-101H7	141.99	7.62	0.61	0.00	0.00	0.00	1.83	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	245.83	65.18	0.40	0.60	0.99	0.40	0.40	0.20
thymus, adult, pool1	10027-101D9	250.43	20.58	1.19	0.40	0.10	0.60	0.70	0.00
thymus, fetal, pool1	10043-101F7	173.21	13.51	0.52	0.21	0.21	0.31	0.10	0.00
thyroid carcinoma cell line:KHM-5M	10776-110G2	194.12	18.48	2.13	0.53	0.13	1.06	0.93	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	107.42	8.52	0.70	0.28	0.00	0.56	0.56	0.14
thyroid, adult, pool1	10028-101E1	181.03	17.64	0.75	0.37	0.19	0.65	0.37	0.09
thyroid, fetal, donor1	10060-101H6	127.61	9.76	1.05	0.53	0.00	0.79	0.26	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	107.79	30.80	0.00	0.00	3.08	0.00	0.00	0.00
tongue, adult	10203-103F5	151.41	54.42	4.19	1.40	1.63	1.40	1.86	0.00
tongue, fetal, donor1	10059-101H5	107.59	14.19	2.36	0.79	0.39	0.00	1.58	0.00
tonsil, adult, pool1	10047-101G2	133.33	34.96	0.70	0.80	0.40	0.20	0.10	0.00
trachea, adult, pool1	10029-101E2	151.16	18.00	0.33	0.82	0.33	0.16	0.16	0.25
trachea, fetal, donor1	10058-101H4	130.80	11.54	0.00	0.38	0.00	1.15	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	207.25	40.39	1.42	0.71	0.35	0.71	1.77	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	428.77	41.74	1.32	2.84	3.14	1.01	0.41	0.81
transitional-cell carcinoma cell line:JMSU1	10492-107B6	150.73	13.95	0.94	0.63	0.63	0.78	1.25	0.00
tridermal teratoma cell line:HGRT	10694-109G1	213.08	36.15	0.00	3.81	0.00	0.00	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	121.47	17.95	0.76	0.25	0.08	0.68	0.59	0.17
umbilical cord, fetal, donor1	10057-101H3	108.50	0.00	2.09	0.00	0.00	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	174.89	8.53	1.02	0.00	0.00	0.17	0.34	0.00
uterus, fetal, donor1	10055-101H1	248.80	23.55	3.58	0.00	0.00	0.51	2.56	0.00
vagina, adult	10204-103F6	121.49	6.46	0.65	0.65	0.00	0.00	0.00	0.00
vein, adult	10191-103E2	91.84	13.59	0.44	0.22	0.44	0.22	0.44	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	69.43	14.15	0.53	0.80	0.00	0.00	0.27	0.00